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Abstract 
Basal body temperature (BBT) and thermoeffector thresholds increase following ovulation in 
many women. This study investigated if solely central thermoregulatory alterations are responsible. 
Seven females in a non-contraceptive group (NCG) were compared with 5 monophasic contraceptive 
users (HCG) on separate accounts: pre-ovulation (Trial I; d 2-5) and post-ovulation (Trial 2; 4-8 d 
post-positive ovulation) for NCG, and active phase for HCG (d 2-5, d 18-21). During immersion in 
28°C water to the axilla, participants exercised for 20-30 min on an underwater ergometer. After 
steadily sweating, immersion continued until metabolism increased two-fold due to shivering. Rectal 
(Tre) BBT was not different between trials for neither NCG (1: 37.34±0.16°C; 2: 37.35±0.27°C) nor 
HCG. At exercise termination, Tre forehead sweating cessation increased (P<0.05) in trial 2 
irrespective of group (1: 37.55±0.39°C; 2: 37.90±0,46°C). Tre shivering onset did not increase 
(P>0.05) in trial 2 (1: 36.91±0.50°C; 2: 37.07±0,45°C). The widths of the interthreshold zone 
increased (P<0.05) in trial 2 (1: 0.64±0.22°C; 2: 0.82±0.37°C) due to the increased sweating threshold 
only. HCG cooled quicker (1: -l.15±0,43°C; 2: -1.00±0.50°C) than NCG participants (1: -
0.58±0.22°C; 2: -0.52±O.29°C), and tympanic (Tty) sweat thresholds were significantly (P<0.05) 
decreased (1: 34.76±0.54°C; 2: 35.39±0.61°C) versus NCG (l: 35.57±0.77°C; 2: 35.89±1.04°C). 
Lastly, Tre and Tty thresholds were significantly different (P<O.05) for all thresholds within the same 
trial. In conclusion, BBT is not a reliable indicator of ovulation, only the central thermoregulatory 
drive for sweating is altered by menstrual phase, contraceptive users have enhanced thermal 
I 
sensitivities, and Tty opposed to Tre provides different measures of core temperature. 
2 
Contents 
Contents ....................................................................................................................................................... 2 
List of tables ................................................................................................................................................ 5 
List of figures .............................................................................................................................................. 6 
List of Abbreviations Used ........................................................................................................................ 7 
Chapter 1- Introduction ............................................................................................................................. 9 
Chapter 2- Review of Literature ............................................................................................................. 12 
1) Female Sex Hormones ................................................................................................................... 12 
i) Secretion ..................................................................................................................................... 12 
ii) Synthesis .................................................................................................................................... 13 
iii) Transport .................................................................................................................................... 14 
2) The Menstrual Cycle ..................................................................................................................... 15 
i) Review ....................................................................................................................................... 15 
3) Hormonal Contraceptives .............................................................................................................. 18 
i) Review ....................................................................................................................................... 18 
4) Temperature Regulation ................................................................................................................ 19 
i) Review ....................................................................................................................................... 19 
ii) Cold Stress Physiology .............................................................................................................. 20 
iii) Heat Stress Physiology .............................................. '................................................................. 20 
iv) Interthreshold Zone .................................................................................................................... 21 
v) Activation and Intensity of Thermoregulatory Responses ......................................................... 22 
5) Menstrual Cycle and Thermoregulation ........................................................................................ 23 
i) Review ....................................................................................................................................... 23 
ii) Cold Stress Phase Differences .................................................................................................... 25 
iii) Heat Stress Phase Differences .................................................................................................... 27 
3 
6) Hormonal Contraceptives and Thermoregulation ......................................................................... 30 
i) Review ....................................................................................................................................... 30 
ii) Cold Stress Phase Differences .................................................................................................... 30 
iii) Heat Stress Phase Differences .................................................................................................... 32 
7) Gaps in the Literature .................................................................................................................... 34 
i) Methodological Challenges ........................................................................................................ 34 
ii) Sex Hormones and the Interthreshold Zone ............................................................................... 35 
8) Summary ....................................................................................................................................... 37 
Chapter 3- Objective and Hypotheses ..............................................................................................•..... 38 
9) Objectives ...................................................................................................................................... 38 
10) Hypotheses .................................................................................................................................... 38 
Chapter 4- Methodology .......................................................................................................................... 40 
11) Participants .................................................................................................................................... 40 
12) Experimental Design ..................................................................................................................... 41 
i. Trial 1 ......................................................................................................................................... 41 
11. Trial 2 ......................................................................................................................................... 42 
13) Determination of the Menstrual Cycle .......................................................................................... 42 
14) Measurements ................................................................................................................................ 43 
15) Data Analysis ................................................................................................................................ 45 
Chapter 5- Results ................................................................... 1, ................................................................ 47 
1) Subject demographic profiles ........................................................................................................ 47 
2) Hormonal contraceptive type ........................................................................................................ 48 
3) Hormonal profiles .......................................................................................................................... 48 
4) Core temperature and skin temperature responses ........................................................................ 49 
5) Metabolic rate and oxygen consumption ....................................................................................... 52 
6) Sweat response .............................................................................................................................. 52 
4 
7) Thermoeffector thresholds ............................................................................................................. 53 
8) Interthreshold zone widths ............................................................................................................ 53 
9) Thermoeffector gains .................................................................................................................... 58 
10) Forehead blood flow ...................................................................................................................... 58 
11) Trial length and thermal votes ....................................................................................................... 59 
Chapter 6- Discussion ............................................................................................................................... 61 
Chapter 7- Conclusions ............................................................................................................................ 70 
1) Conclusions ................................................................................................................................... 70 
2) The direction for future research ................................................................................................... 70 
3) Limitations ..................................................................................................................................... 72 
References ................................................................................................................................................. 73 
Appendices ................................................................................................................................................ 84 
Glossary of Important Terms ...................................................................................................................... 84 
Thermal Comfort Vote ............................................................................................................................... 85 
Thermal Sensation Scale ............................................................................................................................ 85 
5 
List of tables 
Table 2.l. Fluctuations of the female sex hormones .................................................................................. 16 
Table 2.2. Combination contraceptive formulae ........................................................................................ 19 
Table 2.3 Summary ofthe literature- the menstrual cycle and cold response ............................................ 25 
Table 2.4. Summary of the literature- the menstrual cycle and hot response ............................................. 28 
Table 2.5. Summary of the literature- hormonal contraceptives and cold response ................................... 31 
Table 2.6. Summary of the literature- hormonal contraceptives and hot response .................................... 32 
Table 5.1. Subject demographic profiles .................................................................................................... 47 
Table 5.2. Hormonal contraceptive type .................................................................................................... 48 
Table 5.3. Hormonal profiles ...................................................................................................................... 49 
Table 5.4A. Rectal temperature thermoeffector thresholds and interthreshold zone ................................. 54 
Table 5.4B. Tympanic temperature thermoeffector thresholds and interthreshold zone ............................ 54 
Table 6.1. A comparison of dependent variables in the only two studies examining the same participants in 
both heat and cold stress throughout the menstrual cycle .......................................................................... 65 
Table 6.2. A comparison of relative changes in rectal (Tre) and tympanic (Tty) core temperatures following 
varied methods of heating and cooling to the participants in both heat and cold stress throughout the 
menstrual cycle ........................................................................................................................................... 66 
6 
List of figures 
Figure 2.1. Biochemical synthesis of oestradiol and progesterone from the cholesterol precursor ........... 14 
Figure 2.2. Fluctuations of gonadotropic sex hormones throughout the menstrual cycle .......................... 17 
Figure 2.3. Fluctuations of ovarian sex hormones throughout the menstrual cycle ................................... 18 
Figure 2.4. Nervous system control of the effector organs associated with cold and hot temperature 
physiology .................................................................................................................................................. 20 
Figure 2.5. Core temperature interthreshold zone ...................................................................................... 22 
Figure 2.6. Fluctuations in basal body temperature throughout the menstrual cycle ................................. 24 
Figure 2.7. The interthreshold zones between the follicular and luteal phases of the menstrual cycle in 
females not using contraceptives ................................................................................................................ 36 
Figure 2.8. The interthreshold zones between the active and withdrawal phases of the menstrual cycle in 
females using contraceptives ...................................................................................................................... 36 
Figure 4.1. Depiction of data analysis procedure ....................................................................................... 41 
Figure 4.2 Hypothesized hormonal profiles ................................................................................................. 41 
Figure 5.1. Core temperature and skin temperature responses ................................................................... 51 
Figure 5.2. Oxygen consumption versus time ............................................................................................ 52 
Figure 5.3. Sweat rate versus time .............................................................................................................. 53 
Figure 5.4. All thermal variables between groups ...................................................................................... 55 
Figure 5.5A. Trial 1 rectal temperature interthreshold zone .... J ................................................................ 56 
Figure 5.5B. Trial 2 rectal temperature interthreshold zone ....................................................................... 56 
Figure 5.6A. Trial 1 tympanic temperature interthreshold zone ................................................................ 57 
Figure 5.6B. Trial 2 tympanic temperature interthreshold zone ................................................................. 57 
Figure 5.7. Blood flow versus time ............................................................................................................ 59 
Figure 5.8. Trial 1 thermal comfort and thermal sensation between groups .............................................. 60 
List of Abbreviations Used 
17p-estradiol 
Progesterone 
Oral contraceptive 
Oral contraceptives 
Follicular phase 
Luteal phase 
Gonadotropin-releasing hormone 
Luteinizing hormone 
Follicle-stimulating hormones 
Synthetic oestrogen 
Synthetic progesterone 
Heat production 
Heat loss 
Basal body temperature 
Core temperature 
Core temperature shivering threshold 
Core temperature sweating threshold 
Rectal temperature 
Oesophogeal temperature 
Skin temperature 
Mean skin temperature 
Tympanic temperature 
Interthreshold zone 
Rate of oxygen uptake 
Relative rate of oxygen uptake 
Sweat rate 
Perfusion units 
Forearm blood flow 
=OES 
= PRO 
=OC 
=OCs 
=FP 
=LP 
=GnRH 
=LH 
=FSH 
=SO 
=SP 
=HP 
=HL 
=BBT 
= T csh' 
= Tcsw' 
= Tes 
= Tty 
=ITZ 
= ri02 
=SR 
=PU 
=FBF 
7 
Non-contraceptive group 
Hormonal contraceptive group 
Analysis of variance 
=NCG 
=HCG 
=ANOVA 
8 
9 
Chapter 1- Introduction 
During thennal stress, sex dictates thennoeffector responses primarily as a function of 
morphological differences, such as body fat content (Stocks et al., 2004). The notion these differences 
may also be explained by sex honnones requires clarification. The concentrations of ovarian honnones 
that fluctuate throughout the female menstrual cycle are accompanied by changes in internal body 
temperature (Warren & Constantini, 2000). There is general agreement that during the latter half of the 
cycle, the thennoregulatory set point is higher; consequently, basal body temperature (BBT) and 
thennoeffector threshold temperatures increase (Hessemer & Bruck, 1985). Findings are inconsistent 
however, when comparing gains (intensity) of the shivering and sweating responses. Some indicate during 
the luteal phase (LP), shivering is attenuated (Gonzalez & Blanchard, 1998) and sweating is augmented 
(Hessemer & Bruck, 1985). Others find shivering and sweating gains are unchanged between phases 
(Stephenson & Kolka, 1999). Therefore, before the mechanism responsible for sex differences can be 
defined, how the menstrual cycle alters thennoregulation requires elucidation. 
Given that more than 60 million women worldwide rely on the use of orally administered 
contraceptives, research is warranted to clarify the influences of contraceptive use on temperature 
regulation (Van De Graaff et al., 1992). According to current knowledge, tolerance time and cardiac strain 
during heat stress varied throughout the menstrual cycle in females not using contraceptives. However, 
such phase differences did not exist in a honnonal contraceptive group (HCG) (Tenaglia et al., 1999)-
this implies a more unifonn response. On the other hand, similar to non-honnonal contraceptive users, 
BBT and the thennoeffector threshold temperatures remain increased during the active honnone phase 
(Charkoudian & Johnson, 1997). Results also exhibit changes in shivering, but not in sweating gain 
(Grucza, et al., 1993). 
Due to female-specific changes, human thennoregulation has been investigated primarily in 
males. Even more, the little research examining females is isolated to the follicular phase (FP) when sex 
honnones are lowest in concentration. Drinkwater et al. (2000) further notes that research has been 
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influenced by erroneous methods. Errors include inaccurate determination of the menstrual phase, 
variations in basal hormones from chronic training or former exercise bouts, limited sample sizes, 
dissimilar fitness status, and assorted contraceptive prescriptions. 
Throughout these early investigations, participants were exposed to various thermal loads over the 
menstrual cycle course, and thermal responses were monitored both peripherally and centrally. However, 
the thermal influence of sex hormones -oestrogens and progestogens- are believed to be solely central 
(Carpenter & Nunneley, 1988). A model by Mekjavic et al. (1991) was created to clamp mean skin 
temperature (1' sk) involving exercise and subsequent passive cooling while immersed throughout at a 
constant water temperature. Thus peripheral thermoafferents are removed, and central sweating and 
shivering temperature thresholds can be identified (Mekjavic et al., 1991). This same model was used to 
determine morphological sex differences in response to thermal stress; however females were only tested 
during one phase of the cycle (Anderson et al., 1995). Therefore, it is valuable to investigate females using 
the same heating and cooling immersion protocol but taking into account the entire menstrual cycle. 
It is important to broaden the understanding of thermal effects from the menstrual cycle, when 
approximately 8,500,000 women in Canada are affected by cyclical hormone fluctuations (Statistics 
Canada, 2006). Furthermore, contraceptive use is highly popular among females due to successful anti-
fertility rates, and associated health benefits (Drinkwater et al., 2000). In addition, female participation in 
manual labour and athletic events has grown dramatically in recent years (Drinkwater et al., 2000). The-
percentage of females competing in the 1904 St. Louis Olympic Games was 0.9% (1078 participants), 
increasing to 41 % (4329 participants) in the 2004 Greece Summer games (International Olympic 
Committee, 2008). Industrial work, and athletic competition occur in variable conditions that challenge 
women to take on physically demanding activities in extreme heat and cold (Drinkwater et al., 2000). The 
hormonal shifts may predispose females to heat illness or cold injury, and may require modified 
behavioural thermal strategy to maintain optimal physiological function. 
By conducting this study, a greater understanding will be gained about oestrogens and 
progestogens, and their involvement with the hypothalamus to regulate temperature. Results will provide 
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insight on the thermoregulatory differences between sexes, and confirm if thermophysiology is dependent 
on menstrual cycle status. For this investigation, participants will be tested in both menstrual cycle phases. 
Involvement will include normally ovulating females, and a control group prescribed a monophasic 
contraceptive, tested only in the active phase of hormone delivery. By stabilizing T sk, and utilizing a 
"control" group with constant hormonal milieu, results will indicate how fluctuating sex hormones affect 
central control of vasomotor, sweating, and shivering thresholds, and their gains during both hot and cold 
temperature stress. 
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Chapter 2- Review of Literature 
Historically, research has focused on thermoregulatory responses in young, adult males. However, 
the importance of sex-dependent research is recognized more widely as it reflects the increase of female 
participation in activities that are physically demanding, such as athletics (Drinkwater et aI., 2000), and 
industry (Vatter, 1994). When the influence of sex on autonomic thermoregulation is examined, data is 
variable-possibly a resultant of sex-specific hormones. It remains unclear how circulating oestrogens and 
progestogens affect the central control of temperature regulation throughout the menstrual cycle. 
For greater understanding, basic information on sex hormones, the physiological events of the 
menstrual cycle, and the pharmacology of hormonal contraceptives (HC) are discussed. Subsequent 
sections include temperature regulation during thermal stress, and review of the literature quantifying 
thermoregulatory response in females as a consequence of endogenous and exogenous sex hormones. In 
the final section, gaps within the literature are elaborated on. A primary focus of this review is to note 
current trends and conflicts within previous literature. It will not prove or disprove the manner in which 
humans thermoregulate, but rather select one probable model and examine how female hormones 
influence the activation and sensitivity of thermal response with respect to that model. In addition, this 
review will not discuss physiological alterations occurring throughout the menstrual cycle not directly 
associated with temperature regulation. Fluid, metabolic, and cardiovascular alterations have also been 
noted between phases but are detailed by others (Drinkwater et aI., 2000). 
1) Female Sex Hormones 
i) Secretion 
Female endocrinology is well understood, and clearly described by Fox (2000). The hypothalamus 
secretes gonadotropin releasing hormone (GnRH) following puberty. GnRH promotes the anterior 
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pituitary gland to secrete the gonadotropic hormones, follicle stimulating hormone (FSH) and luteinizing 
hormone (LH). FSH and LH are termed as such because their secretions cause the gonads (ovaries) to 
form egg cells that secrete oestrogens and progestogens. Oestrogens and progestogens are the dominant 
female sex hormones that maintain ovarian function (Fox, 1990). There are multiple oestrogens and 
progestogens, but 17~-oestradiol (OES) and progesterone (PRO) circulate in the greatest concentrations, 
and thus cause the majority of the reproductive effects (Johnson, 2008). Therefore, OES and PRO will 
represent all oestrogens and progestogens in this review. 
ii) Synthesis 
There are numerous hormones secreted by the endocrine system, yet only the steroid hormones 
are pertinent to this review. OES and PRO are two steroids derived from cholesterol precursors (Griffin & 
Ojeda, 2000). The functional chemical groups attached to the cholesterol hydrocarbon backbone will 
distinguish one hormone from the other (Fox, 1990). PRO is synthesized via direct conversion 
(aromatization) from a derivative of cholesterol (Fox, 1990). OES synthesis is more complex, requiring 
PRO aromatization and subsequent aromatization of associated sex hormones, androstenedione and 
testosterone (Fox, 2000). Simplified below (Figure 2.1.) is a schematic ofOES and PRO synthesis. 
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Figure 2.1. Biochemical synthesis of oestradiol and progesterone from the cholesterol precursor (from 
Fox, 1990). 
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iii) Transport 
Unlike nervous system transmission, communication from sex hormones may continue for days 
(Saladin, 2001). OES and PRO are released into the bloodstream and transported to their target cells 
loosely bound to plasma-binding proteins. Following transport, OES and PRO attach to receptor sites on 
the target cells and form hormone receptor-complexes (Griffin & Ojeda, 2000). The complexes are 
contained within the nucleus, but may also be present on the membrane or in other organelles. Once the 
high affinity OES and PRO complexes are formed, the receptors' structures are altered and activated to 
synthesize new proteins (Griffin & Ojeda, 2000). These p~oteins then carry out the typical hormonal 
responses on the target cells (Saladin, 2001). Dependent on the hormone and cell interactions, these 
responses occur immediately at the membrane of the target tissue, or are fed forward to release other 
hormones eventually altering the target cells (Griffin & Ojeda, 2000). 
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2) The Menstrual Cycle 
i) Review 
It is further important to understand the function of the female sex hormones during the course of 
the menstrual cycle. The cooperative secretion, synthesis, and transport of the hormones stimulate the 
events that comprise the menstrual cycle phases (Van De Graaff et aI., 1992). Van De Graaff et al. (1992) 
described the cycle as it spans over the approximate 28-day time course. In brief, the menstrual phase 
occurs on day one and typically lasts through day five. The follicular phase (FP) is to follow--days 5 to 
14-when an egg cell grows, transforms into a follicle, and progressively secretes OES. When LH and 
OES reach critical levels on approximately day 14, the follicle is ovulated and released. During the luteal 
phase (LP)--days 15 to 28-primarily PRO is secreted from the follicle until cell death. When PRO and 
OES concentrations decrease, the beginning of the cycle is reached again. The following table (Table 2.1.) 
summarizes the principal functions of the sex hormones, while the figures (Figures 2.2. and 2.3.) depict 
the normal concentration fluctuations throughout the cycle. 
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Table 2.1. Functions of the female sex hormones (Johnson 2008) and their hypothesized thermal 
physiological effects. 
Hormone Functions Thermal physiological effects 
GnRH • Secreted from the hypothalamus 
• Initiates secretion of LH and 
FSH 
LH • Secreted from the anterior 
pituitary gland 
• Triggers ovulation 
• Converts the follicle into the 
corpus luteum 
FSH • Secreted from the anterior 
pituitary gland 
• Initiates follicular growth 
OES • Secreted primarily from the • Decreases basal body temperature 
follicles in the ovaries (Carpenter & Nunneley, 1988) 
• Promotes female secondary sex • Decreases core temperature during 
characteristics exercise (Carpenter & Nunneley, 1988) 
• Causes the LH surge to trigger • Decreases sweating threshold 
ovulation (Stephenson & Kolka, 1999) 
• Thickens the endometrium 
• Inhibits further LH and FSH 
secretion 
PRO • Secreted from the follicles in the • Increases basal body temperature 
ovaries (Hessemer & Bruck, 1985) 
• Develops the fetus • Decreases thermal conductance in a 
• Increases water and sodium neutral environment (Frascarolo et aI., 
excretion from the kidneys 1990) 
• Inhibits further LH and FSH • Increases sweating and vasodilator 
secretion thresholds (Kolka & Stephenson, 1989) 
• Increases shivering thresholds 
(Hessemer & Bruck, 1985) 
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Figure 2.2. Fluctuations o/the gonadotropic sex hormones throughout the menstrual cycle (modifiedfrom 
Marieb,1988). 
60 
'*" 
'" ::: 50 S 
? 
... 40 1% 
1: 
;Q 30 ... 
<:e 
"'-' 
~ 20 ~ 
a;> 10 :::: 
<:> § 0 Q 
-= 0 c: 
e 
eo: 
~ 
Fluctuation of gonadotropin levels 
5 
...... 
. . 
. " . . . . 
............... ..- ••••••• IIi< ................... ~ ....... ". 
••••••• .* ............... . 
10 15 20 25 30 
l\Ienstrllal cycle time course (days) 
-ill ....... FSH 
Figure 2.3. Fluctuations o/the ovarian sex hormones throughout the menstrual cycle (modifiedfrom 
Marieb,1988). 
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3) Hormonal Contraceptives 
i) Review 
There are multiple forms ofHC available. Their prevalence has increased, with approximately 60 
million worldwide prescribed on oral ingested contraceptives alone (Van De Graaff et aI., 1992). Most 
contraceptives are combination in nature, and consist of synthetic oestrogens (SO) and synthetic 
progestogens (SP). With administration on "day one," contraception is achieved as plasma SP 
immediately increases. Greater SP content deters FSH and LH secretion, disallows follicle maturation, 
thus OES secretion. Positive feedback from OES does not occur, prevents the surge in LH, and inhibits 
ovulation (Van De Graaff et aI., 1992). Depending on the type of contraceptiv.e, SO and SP concentrations 
can vary or remain the same. Regardless of the type, one package provides three weeks of exogenous 
hormonal dose, called the active phase. In the fourth week, the contraceptive is no longer administered, 
called the withdrawal phase. During withdrawal, SO and SP concentrations quickly decrease, and allow 
for menstruation (Fox 2000). The table below (Table 2.2.) summarizes the three different forms of 
combination contraceptives offered. 
Table 2.2. Combination contraceptiveformulae. 
Combination (SO and SP) 21 active doses, 7 placebo or inactive doses 
Monophasic 21 d steady hormone dose 
Biphasic Hormone dose IS changed once throughout the active 
formulation; reducedl total hormone dose 
Triphasic Varying hormone content every 7 d; best mimics endogenous 
hormone shifts; least amount of total hormone dose 
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4) Temperature Regulation 
i) Review 
Having discussed female specific endocrinology, it is important to clarify particular facets of 
autonomic thermoregulation. During acute exposure to extreme cold or hot environments, physiological 
strain increases. The thermoregulatory and cardiac systems work synchronously to limit core temperature 
(Tc) change by regulating heat storage. For optimal function and health, Tc maintains relatively constant-
approximately 37°C-rendering humans as homoeothermic (Folk, 1974). The hypothalamus contains cold 
and warm sensitive neurons, located in different regions of the pre-optic anterior region (see Figure 2.4.) 
(Reilly & Waterhouse, 2005). Temperature insensitive neurons are also found in this region (Silva & 
Boulant, 1986). The temperature sensitive neurons receive thermal afferents from peripheral and central 
thermoreceptors. Those in the periphery are located variably throughout the skin-surfaces, and mucous 
membranes. The spinal cord, brain and hypothalamus contain the temperature sensitive neurons specific to 
the core (lUPS, 2001). After the hypothalamus integrates the thermal information from both receptor-
types, effector organs are stimulated to initiate heat production or heat loss (Marieb, 1988). During 
exposure to the cold, metabolic heat is generated and stored in the body. Conversely, excess metabolic 
heat that is produced in the heat is dissipated. The amount of heat-energy transferred is predominantly 
dependent on the duration and severity ofthe environment (Marieb, 1998), while the magnitude and 
direction determine the extent ofTc change. 
Figure 2. 4. Nervous system control of the effector organs associated with cold and hot temperature 
physiology (from Reilly & Waterhouse, 2005). 
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Upon activation of the posterior hypothalamus, two effector mechanisms are initiated, cutaneous 
vasoconstriction and shivering thermogenesis. During vasoconstriction, tissue insulation increases to 
reduce convective heat loss up to one-third (Folk, 1974). When the cold stress is substantial, skeletal 
muscles contract to produce heat, further conserved with vat'oconstriction (Stocks et ai., 2004). These 
involuntary-asynchronous-contractions can elevate metabolic heat production four-to-six fold (Folk, 
1974). 
iii) Heat Stress Physiology 
The warm-sensitive-anterior-hypothalamus processes thermal afferents signalling that blood, Te, 
and skin temperature (T sk) are exceedingly warm. These impulses activate two effector responses, 
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cutaneous vasodilatation and sweat gland secretion. As blood vessel diameter increases, blood shunts to 
the periphery, and central blood flow reduces (Folk, 1974). Vasodilatation dissipates the heat in the blood 
by increasing dry heat exchange to the environment (Marieb, 1988). If the heat stress is great enough, the 
eccrine sweat glands are triggered to release biological fluid. Sweating removes heat through the phase 
change and evaporation of the water off the skin's surface (lOPS, Thermal Commission, 2001). 
iv) Interthreshold Zone 
The responses to cold and heat stress are well understood, though it is debated precisely how 
hypothalamic temperature is perceived and thermoeffector responses initiated (Flouris, 2008). There are 
multiple models proposing the mechanisms of neuronal activation and integration of peripheral and 
central afferents. Some favour a model in which effectors are activated when an internal set point 
temperature deviates from a consistent value (Hammel, 1968); this "set point" theory suggests T c is 
continuously compared to a reference temperature, and ftres an error signal when changed by a particular 
value (Cabanac & Massonnet, 1977). The error signals diminish eventually when vasomotion, shivering or 
sweating are activated (Mekjavic & Eiken, 2006). In turn, a large deviation from the reference temperature 
is avoided (Hammel et aI., 1968). Others conclude that sweating and shivering occur at particular 
thresholds, and are absent through a range of internal temperatures (Mekjavic, 1991). In this 
"interthreshold zone" (ITZ) theory, neither shivering nor sweating occur as long as Tc is within 
temperature limits (Mekjavic, 1991). Kakitsuba et ai. (2007) demonstrated shivering and sweating are also 
examined along an abscissa of peripheral temperatures to indicate the presence of both peripheral and 
, 
central ITZs. Whether the thresholds are identifted using Tc or Tsk, only vasomotor activity occurs within 
the ITZ, and precedes the onset of sweating and shivering as depicted in the ftgure below (Figure 2.5.). 
However, there is variance in thermal thresholds and intensities (gains) due to inter-individual and non-
thermal factors (Kakitsuba et aI., 2007) including exercise, blood glucose, hydration state, sleep, motion 
sickness, and fever (as referenced by Mekjavic & Eiken, 2006). 
Fig. 2.5. Core temperature interthreshold zone (from Mekjavic & Eiken, 2006). Note the variability of 
thresholds and gains for each ejJector response as represented by the arrows from individual and non-
thermal factors. 
Interthreshold Zone 
Peak HP Peak HL 
Core temperature 
v) Activation and Intensity of Thermoregulatory Responses 
22 
::c 
rtl 
OJ 
.... 
0-
VI 
VI 
When identifying the Tc that corresponds with vasomotor, thermogenic (shivering) or sudomotor 
(sweating) onsets, the terms thermoejJector threshold and thermoejJector threshold temperature are used. 
The !UPS Thermal Commission (2001) defined the threshold as: "The level of activity of a potential 
thermoeffector that is transgressed when it becomes actively involved in temperature regulation," and the 
threshold temperature as: "The level of a specified body temperature ... which in one direction, either 
upward or downward, will activate a certain thermoeffector" (IUPS Thermal Commission, 2001). 
Experimentally there are many ways to quantify vasomotor thresholds, such as forearm blood flow 
(Brengelmann & Savage, 1997), local Tsk(Daanen, 2003), verious occlusion plethysmography (Hessemer 
& Bruck, 1985) and laser-Doppler flowmetry (Wilson et aL, 2007). Studies quantifying shivering 
thresholds utilized electromyography (Bittel et al., 1988) or rate of oxygen uptake (ll02) (Anderson et al., 
1995). Shivering onset occurs when VOz doubles the resting rate (Mekjavic et al., 1991), and reflects the 
contractile forces of large muscles. Although there are multiple methods, to determine sweating onset, 
ventilated sweat capsules can be utilized (Carpenter & Nunneley, 1988). 
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Another important thermal characteristic is gain. One common method of calculating gain is 
through portraying the response's activity as a function of Te and calculating the slope of the linear plot 
created; a steeper slope indicates greater response intensity in a given thermal load, as shown by the grey 
arrows in Figure 5. and the angle of the diagonal line with the horizontal (Kolka & Stephenson, 1989). 
Both the threshold and gain of a thermophysiological response affect the rate of change in Te. 
During cold stress, quicker vasoconstriction onset will enhance heat preservation, maintain thermal 
balance without maximal shivering, and delay time to hypothermia (Haman, 2006). Conversely, quicker 
vasodilatation onset enhances heat loss, while earlier and greater sweat output attenuates risk of 
hyperthermia (Armstrong, 2000). 
At present, there are substantially more data on male thermal response. As a result, further 
research is required on female specific thermal thresholds and gains. Provided that Te fluctuates due to 
endocrinology, thermoregulation is more variable, and may increase risk of hypo- or hyperthermia in 
extreme conditions. 
5) Menstrual Cycle and Thermoregulation 
i) Review 
In previous findings, sex affected rates of relative heat storage (McLellan, 1998), sweating 
dynamics (Bittel & Henane, 1975), and thermogenesis (McArdle et ai., 1984), as a result of different 
body morphology and composition: likely sex hormones have an influence as well. Literature comparing 
sexes conducts tests during the FP only when concentrations of.OES and PRO are low, and the hormonal 
milieu less influential (Kaciuba-Uscilko & Grucza, 2001). However, studies that examine females across 
the entire menstrual cycle indicate thermoregulation changes as hormones fluctuate. It is well documented 
that Te increases 0.3°-0.7°C following ovulation, and is sustained during the LP when PRO content is 
greatest (Gonzalez & Blanchard, 1998; Hessemer & Bruck, 1985; Horvath & Drinkwater, 1982). 
Conversely, there is a rapid decrease in Te when OES content peaks prior to ovulation (Stephenson & 
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Kolka, 1999). The figure below (Figure 2.6.) demonstrates these shifts in basal body temperature (BBT) 
pre- and post-ovulation in normally menstruating females. Since Tc fluctuations occur, sex-specific 
thermoregulation remains ambiguous. 
Fi ure 2.6. Fluctuations in basal body tern erature throu hout the menstrual cycle om Marieb, 1988). 
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Although there are numerous hypotheses, a probable mechanism of BBT shifts is the hormones 
altering firing rates of the temperature-sensitive neurons (Nakayama et aI., 1975; Silva & Boulant, 1986). 
Nakayama et al. (1975; action of PRO on preoptic thermosensitive neurons) administered PRO to rats, and 
noted the firing rates of warm-sensitive neurons decreased, while those of cold sensitivity increased; heat 
loss responses dampened, heat production was activated, and BBT increased. Further, Silva & Boulant 
\ (1986) found with OES administration to hypothalamic tissue slices, activity of the warm-sensitive 
neurons increased, whereas the cold-sensitive neurons were inhibited or unaffected. In this experiment, 
heat loss was promoted, and therefore, decreased BBT. 
Similar shifts in BBT have been documented in humans, as well as alterations to thermoeffector 
thresholds and gains. It is unsurprising that during the LP, heat loss and heat production are activated at 
higher internal temperatures when BBT is increased (Hessemer & Bruck, 1985). The following section 
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will review the data, and compare thermoregulatory responses between the FP and LP during cold, hot 
and/or exercising stresses. 
ii) Cold Stress Phase Differences 
Greater PRO content stimulates metabolic heat production and raises BBT in a thermoneutral 
condition. Therefore, when exposed to cold stress, Tc thresholds for further heat production increase to 
allow for vasoconstriction and shivering activation at higher absolute T c (Hessemer & Bruck, 1985). 
Given that BBT is shifted upwards, heat production at a higher Tc accommodates this change. 
Furthermore, shivering gain is reduced during the LP; presumably, there is less need for intense shivering 
at higher temperatures (Gonzalez & Blanchard, 1998). In agreement, Hessemer & Bruck (1985) found that 
post-ovulation, the rate of heat debt is decreased during passive cold stress. Interestingly, heat production 
is activated following similar relative decreases in Tc regardless of menstrual phase, though the intensity 
of the vasoconstriction and shivering responses will be dulled post-ovulation. Taken together, cold 
tolerance may improve during the LP with an increase in, and maintenance of, higher BBT. To highlight 
specific experiments subjecting females to cold throughout both menstrual phases, refer to Table 2.3. 
below. 
Table 2.3. Summary of the literature- the menstrual cycle and cold responses. 
Reference Subjects Thermal load Significant results 
Kenshalo 3 untrained • Detection of peripheral All results during LP and when T ~ 
(1966) females cold sensation thresholds ada12ted to higher tem12eratures 
following manipulation of only· 
initial Tsk (30° - 40°C) • Increased cold 
• Used copperibismuth ~ sensitivity 
plates placed over the • Increased vasodilatation 
forearms for thermal stimuli 
• Daily testing throughout 
three consecutive menstrual 
cycles 
• Menstruation vs. FP vs. 
LP 
Hessemer& 10 females: • Ramp cooling from 32° to All results during LP 
Bruck (1985) 9 untrained, 12°C until metabolic rate Pre-exposure: 
1 trained increases 100% • Increased T c 
• Subiects passive • Increased T sk 
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• FP (4-7 d post- • Increased basal metabolic 
menstruation) vs. LP (4-8 d rate 
post-ovulation) • Increased arm blood flow 
• Increased heart rate 
Cold exposure: 
• Shivering onset 
threshold increased 
• Decreased respiratory 
exchange ratio while shivering 
• Decreased electrical 
muscle activity while 
shivering 
Gonzalez & 6 trained • 80 min ramp cooling from All results during LP 
Blanchard females 20° to _5°C Pre-exposure for both ensembles: 
(1998) • Donned 2 ensembles: A) • Increased T c 
less thermal resistance, B) For A ensemble only: 
more thermal resistance • Decreased end Tc 
• FP (d 2-6) vs. LP (d 19- • Decreased rate of heat 
23) debt 
• Increased mean heat flux 
due to decreased 
vasoconstriction 
For both ensembles: 
• Decreased shivering gain 
• No phase differences in 
shivering threshold 
Klentrou et 7 pre- • 40 min cycling at 30% • Trends for greater thermal 
al. (2004) menarcheal, maximal oxygen uptake in comfort and less thermal 
6 menarcheal 5°C sensitivity during FP 
adolescent • FP (d 1-5) vs. LP (d 19- • No phase differences in 
females 22) shivering response or T c 
As indicated above, females may be better protected during the LP in the cold. Tolerance is 
enhanced post-ovulation: the rate of heat debt decreases (Gonzalez & Blanchard, 1998), as the shivering 
threshold (Hessemer & Bruck, 1985), and peripheral cold sensitivity increase (Kenshalo et aI., 1966). 
1 
Unfortunately, these studies cannot confirm the mechanism causing such phase differences, and 
report various hypotheses as a consequence. For instance, Gonzalez and Blanchard (1998) suggested 
decreased shivering intensity due to competitive inhibition between the cold afferents and warming effect 
of PRO in the hypothalamus. Meanwhile, the lack of cold response differences in the menarcheal group 
from the study by Klentrou et al. (2004) does not provide mechanistic insight, except for an understanding 
that phase differences rely on gynaecological age. Most are in agreement, however, that the sex hormones 
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are centrally acting, and thus affect the entire thermoregulatory system and multiple organs. This central 
hypothesis is supported by data illustrating the thresholds for sweating and shivering are altered in the 
same direction, and to a similar magnitude (Hessemer & Bruck, 1985). Furthermore, the adjustments to 
BBT are in opposing directions, but comparably concentration dependent, pre- and post-ovulation 
(Marrone et al., 1976). These parallel alterations would not occur if the hormonal effects were solely 
peripheral in nature as hypothesized by Kenshalo (1966). In this study, phase shifts were noted in 
vasomotor activity and sensitivity only, and not BBT (Kenshalo et al., 1966). The protocol used, however, 
was highly influenced by the periphery since cooling was applied to only one surface region of the body. 
It is evident from the aforementioned studies, that a precise mechanism for phase alterations is 
unknown. Whether changes are centrally or locally driven remains unclear as both cutaneous and whole 
body responses differed. Protocols involving transient cooling, local skin cooling, and exercise are 
confounded by changing Tsk and peripheral thermoafferents. Better control of thermal input from the 
periphery is required to elucidate whether PRO and OES affect only the hypothalamus, the periphery, or 
their integration. 
iii) Heat Stress Phase Differences 
Literature supports that the increase in BBT during the LP remains elevated during exercise or 
heat exposure (Pivamik et al., 1992). Further, activation of heat loss-vasodilatation and sweat-is 
delayed to greater absolute Tc values when inclined to regulate at higher temperatures (Hessemer & 
Bruck, 1985; Kolka & Stephenson, 1989; Stephenson & Kolka, 1999). It is logical that thermoeffector 
thresholds shift. Otherwise, convective and evaporative heat loss would occur when normothermic, and 
profuse sweating would occur during heating or exercise. In addition, some found sweat gain increases to 
oppose a higher Tc (Hessemer & Bruck, 1985). However this finding is not consistent, and is demonstrated 
in Table 2.4. following a comparison of protocols that increase Tc throughout both phases of the menstrual 
cycle. 
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Table 24. Summary of the literature- the menstrual cycle and hot responses. 
Reference Subjects Thermal load Significant results 
Horvath & 4 untrained • 25 min walking at 30% All results during LP 
Drinkwater females maximal oxygen uptake in Pre-exposure: 
(1982) 28°C, 35°C, and 48°C • Increased resting T c 
• Menstruation vs. • Increased resting i'02 
ovulation vs. LP 2SOC only: 
• Decreased forearm blood 
flow 
• Decreased T sk 
35°C only: 
• Decreased stroke volume 
• Increased T c when t= 5 
min, 25 min 
48°C only: 
• Increased evaporative 
heat loss 
• Greater relative decrease 
in plasma volume 
Hessemer& 10 females: • Ramp heating from 18° to All results during LP 
Bruck (1985) 9 untrained, 59°C until 12-15 min post- Pre-exposure: 
1 trained sweat onset • Increased T c 
• Subjects passive • Increased T sk 
• FP (4-7 dpost- • Increased basal metabolic 
menstruation) vs. LP (4-8 d rate 
post-ovulation) • Increased arm blood flow 
• Increased heart rate 
Heat exposure: 
• Increased chest sweat 
threshold 
• Increased vasodilatation 
threshold 
• Increased cutaneous heat 
conductivity (heat flux) 
• Increased rate of change 
in cutaneous heat conductivity 
• Increased T c ~ Increased T sk • 
• Increased chest sweat rate 
• Increased sweating gain 
• Increased heat 
conductivity gain 
Kolka & 7 untrained • 160 min in 50.4°C All results during LP 
Stephenson females • Subjects passive • Increased sweating 
(1989) • 9 min cycling at 80% threshold 
maximal oxygen uptake in • Increased T sk 
50.4°C • No phase differences in 
• 35 min cycling at 85% sweat gain 
maximal oxygen uptake in • Greater norepinephrine 
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35°C content 
• FP (d 4-7) vs. LP (d 19- • Decreased subjective 
22) tolerance 
Stephenson 6 females: • Walking to volitional All results during late FP 
& Kolka 4 trained exhaustion in 30°C • Decreased resting T c 
(1999) soldiers, 2 • Early FP (d 2-6) vs. late • Decreased sweating 
civilians FP (d 9-12) threshold 
• No phase differences in 
sweat gain 
In brief, females may be at a disadvantage in the heat during the LP. Vasodilatation and sweating 
are delayed, concurrent with elevated BBTs (Hessemer & Bruck, 1985; Kolka & Stephenson, 1989). 
Physiological strain is exacerbated as norepinephrine concentration (Kolka & Stephenson, 1989), heart 
rate (Hessemer & Bruck, 1985), V02, and fluid losses (Horvath & Drinkwater, 1982) increased more 
during exercise; Tc and Tsk are higher, and reduce the thermal gradient to lower heat dissipation capacity 
(Kolka & Stephenson, 1989; Hessemer & Bruck, 1985). There is debate whether or not sweat gain 
increases, as only some found enhanced sweat sensitivity (Hessemer & Bruck, 1985). As a result, it is 
unclear whether central sensitivity or sweat gland output is altered when peripheral and central 
thermoregulation is not separated. Further, phase differences may be masked when exercise and heat 
stress are combined, versus heating passively (Horvath & Drinkwater, 1982). 
The experiments summarized above imply increased PRO concentration is responsible for 
vasomotor and sudomotor threshold delays. As previously described, PRO is hypothesized to increase 
cold-sensitive neuronal activation, and regulates the core at elevated temperatures (Nakayama et aI., 
1975): heat loss thresholds are adjusted accordingly. Vasodilatation and sweating thresholds are activated 
following similar relative Tc increases as the FP, but occut at a higher absolute Tc during the LP. 
Ultimately, the precise mechanism whereby increased PRO triggers heat loss phase differences is elusive. 
A protocol is required to segregate peripheral and central afferents to determine how the thermoeffector 
thresholds and gains are affected by fluctuating sex hormones. 
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6) Hormonal Contraceptives and Thermoregulation 
i) Review 
Given the prevalent use of HC, thennoregulation in conjunction with exogenous honnone use 
warrants investigation. Current knowledge shows that despite consistent honnonal doses, BBT and 
thennoeffector thresholds significantly increase in the latter course of honnone delivery (Charkoudian & 
Johnson, 1999; Grucza et ai., 1993). These shifts are not influenced by HC but must result from an 
inevitable influence of the menstrual cycle, provided that the same shifts occur in females not utilizing HC 
(Grucza et aI., 1997). Data investigating thennoregulatory gains however, are more controversial. Some 
showed HC minimized differences during exercise stress (Grucza et ai., 1993), while others found 
temperature regulation differences only in HC users (Annstrong et ai., 2005). In other words, HC may 
alter the intensities of thennal responses due to a more subtle impact from the menstrual cycle, and 
contribute to conflicting findings (Grucza et aI., 1997). 
ii) Cold Stress Phase Differences 
As BBT increases near the end of the active phase, shivering and vasoconstriction Tc thresholds 
shift upwards (Charkoudian & Johnson, 1999; Grucza et aI., 1997). Elevated absolute onset temperatures 
cause Tc to regulate around a higher value throughout cooling. However, shivering gain data is equivocal. 
Some indicated intensity significantly increased during the quasi-FP (Grucza et aI., 1997), while others 
found it is unaltered between low and high honnone phases (Charkoudian & Johnson, 1999). The fonner 
1 
study compared females during the high dosage only, while the latter compared females during both 
placebo and high honnone dosages. Therefore, honnonal status was different between studies. To further 
compare the documentation, below is Table 2.5. highlighting some protocols, and pertinent results of 
females using HC exposed to cold. 
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Table 2.5. Summary of the literature- hormonal contraceptives and cold response. 
Reference Subjects Thermal load Significant results 
Grucza et a1. • 7 untrained • 30 min in 3.4°C All results during guasi-LP 
(1997) females • Subjects passive Pre-exposure: 
• All • Quasi-FP (d 9-10) vs. • Increased BBT 
monophasic quasi-LP (d 22-23) Cold exposure: 
HC • Increased T c 
prescribed • Increased shivering threshold 
• Increased time to shiver onset 
• Decreased shivering gain 
• Decreased heart rate 
• Decreased respiratory rate 
Charkoudian • 8 untrained • Ramp cooling ofTsk from All results during high hormone 
& Johnson females 36°C at a rate of phase 
(1999) • All 0.2°C·min-1 for 12-15 min Pre exposure: 
monophasic • Water perfused suit • Increased BBT 
HC • Subjects passive Cold exposure: 
prescribed • Low hormone phase vs. • Increased T c 
high hormone phase • Increased cutaneous 
(precise days undefined) vascular conductance 
threshold (vasoconstriction 
threshold) 
• No phase differences in 
cutaneous vascular 
conductance slope 
These studies confirm vasoconstrictor and shivering onsets occur at elevated thresholds, and 
support the endogenous effect of the menstrual cycle overrides HC influences on BBT and activation 
thresholds. However, whether cold sensitivity is dampened or unaltered between phases remain uncertain. 
All subjects were prescribed a monophasic HC, yet testing took place during different HC doses, likely 
, 
causing disparate fmdings. Had the females been tested during the inactive phase in the study by Grucza et 
a1. (1997), a clearer understanding of effector gains would result, and significant differences may have 
disappeared. Furthermore, either study did not compare with non-HC users that could provide further 
insight. 
Interestingly, Grucza et a1. (1993) found sweating gain was indifferent between the quasi-FP and 
quasi-LP. Alterations in only shiver gain suggest HC affect heat loss and production through different 
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mechanisms. On the other hand, Charkoudian & Johnson (1997) found vascular response is equally 
altered during heat and cold stress. These findings would support SO and SP act in the same manner, and 
that the mechanism is centrally driven. Although conflicting findings may be attributable to methodology, 
data is limited, and further investigation is required to better understand the influence of HC on cold 
response sensitivity. 
iii) Heat Stress Phase Differences 
Although females that utilize HC exhibit an upwards shift in the temperature set point mid-
hormone delivery, physiological stress in the heat is suppressed. In normally ovulating females, 
cardiovascular strain increases during heat exposure post-ovulation. In contrast, females with high SO and 
SP content portrayed decreases in heart and sweat rates for a given Te (Charkoudian & Johnson, 1997). 
Furthermore, HC use did not alter sweating intensity, (Grucza et aI., 1993), vasodilator gains 
(Charkoudian & Johnson, 1997), and exercise tolerance time across active and withdrawal phases 
(Tenaglia et aI., 1999). Taken together, during transient increases in Te, thermoregulation is more uniform 
between menstrual phase, and physiological strain is minimized with HC use. The data are summarized in 
Table 2.6. below, that investigate the influence ofHC during exposure to heat throughout the menstrual 
cycle. 
Table 2.6. Summary of the literature- hormonal contraceptives and hot response. 
Reference Subjects Thermal load Significant results 
Grucza et ai. • 20 untrained • 45 min cycling at 50% All results during guasi-LP: 
(1993) females maximal oxygen uptak~ He users only, pre-exposure: 
• 8 triphasic in 24°C • Increased BBT 
HC • Quasi-FP vs. quasi-LP Exercise: 
prescribed, 2 (precise days undefined) • Increased T e 
monophasic • FP (d 5-8) vs. LP (d 18- • Increased sweating 
HC 24) threshold 
prescribed 
• IOnon-HC • No phase differences in 
users sweat gain 
Charkoudian • 7 untrained • Ramp heating of T sk to All results during high hormone 
& Johnson females 38SC for 30-45 min phase 
(1997) • All • Water perfused suit Pre-exposure: 
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monophasic • Subjects passive • Increased BBT 
HC • Low hormone phase vs. Heat exposure: 
prescribed high hormone phase • Increased vasodilator 
(precise days undefined) threshold 
• Increased sweat threshold 
• Decreased heart rate for a 
given Tc 
• Decreased sweat rate for a 
given Tc 
• No phase differences in 
cutaneous vascular 
conductance slope 
• No phase differences in 
sweat gain 
Tenaglia et • 18 untrained • Alternating 15 min All results during guasi -LP 
al. (1999) females walking with 15 min He users only, pre-exposure: 
• 7 monophasic resting until volitional • Increased BBT 
HC exhaustion in 40°C Heat exposure: 
prescribed, 2 • Donned nuclear • Increased T c 
triphasic HC biological chemical • No phase differences in 
prescribed ensemble tolerance time 
• 9 non-HC • Quasi-FP (d 2-5)vs. 
users quasi-LP (d 19-22) • No phase differences in sweat 
• FP (d 2-5) vs. LP (d 19- gam 
All results during LP: 
22) Non-He users only, pre-exposure: 
• Increased BBT 
• Increased T sk 
Heat exposure: 
• Decreased tolerance time 
• Decreased ~ T c 
• No phase difference in sweat 
gain 
Armstrong • 36 untrained • 8 wk indoor heat All results during 12ost-HAPT: 
et al. (2005) females acclimatization and He users only: 
• 9 monophasic outdoor physical trainihg • Decreased sweat threshold 
HC (HAPT) • Decreased time to sweat onset 
prescribed, 6 • FP (d 2-5) pre-HAPT vs. (minutes) 
triphasic HC FP (d 2-5) post-HAPT 
prescribed 
• 7 injected 
contraceptive 
prescribed 
• 14 non-HC 
users 
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Often monophasic HC users serve as a control group in experimentation due to streamlined 
hormonal profiles; therefore, the majority of these participants were prescribed this type that could 
eradicate mid-cycle changes. In support, minimal differences were notied in sweat gain (Charkoudian & 
Johnson, 1997; Grucza et al., 1993). Interestingly, BBT and effector thresholds are similarly increased 
during the active phase in these individuals. The shifts are likely due to a natural tendency of the 
menstrual cycle that HC cannot supersede, and suggest a link between the thermoregulatory and 
reproductive systems that is susceptible to change without ovulation occurring. Unfortunately, these 
results cannot determine whether BBT and threshold-alterations occur at the periphery. SP in the plasma 
may perfuse the blood vessels and sweat glands, plausible to modify the vasomotion or fluid output, 
respectively. It is also possible the synthetic hormones influence central drive to elevate response 
thresholds. Although equivocal, the latter hypothesis is generally agreed upon. Future studies should 
remain examining monphasic HC users, but isolate central from peripheral thermal information to better 
quantify thermal responses. 
7) Gaps in the Literature 
i) Methodological Challenges 
Upon realizing little is clarified about female thermoregulation, many have applied thermal stress 
in combination with fluctuating sex hormones. Unfortunately, current knowledge is limited due to variable 
methods and subject characteristics, or inaccurate determination of the menstrual phase status. Changes in 
Te involve the integration of central and peripheral thermal infdrmation (Simon, 2000), yet it is difficult to 
determine if the sex hormones affect the integration of the afferents, or solely central or peripheral control. 
Most suggest the effects are centrally occurring (Carpenter & Nunneley, 1988; Hesemer & Bruck, 1985), 
but findings are largely influenced by variations of Tsk. It cannot be clarified which thermal receptors are 
affected when effector gains are plotted as a function of body temperature derived from Tsk and Te. 
Defining the intensity of thermal responses as a change in either Tsk or Te alone, may eliminate 
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controversy and explain the mechanistics of thermoregulatory alterations. Unique findings may also be 
due to the time of day subjects were exposed to thermal stress. The study by Hessemer & Bruck (1985) 
was conducted between 03:00-04:30h when the BBT shift is most apparent. As well, the amplitude of 
circadian variation in Tc is less during the LP (Coyne et ai., 2000), and thus warrants consideration. 
The experimental conditions are widely variable between studies, allowing for different thermal 
inputs and potentiating discrepancy in effector gains. Subject fitness status ranged from adolescent 
gymnasts and military trained to untrained. Whether responses can be extrapolated for the entire female 
population is unclear. Furthermore, determining the menstrual phase was not always accomplished most 
accurately. For example, in Kenshalo (1966) the menstrual cycle phase was determined by charting BBT. 
Although ovulation is typically characterized by a sudden increase in BBT, this method relies on subject 
responsibility, and is susceptible to variability (Coyne et aI., 2000). Lastly, studies examining HC users 
take varying pill types (monophasic and triphasic), and the dates of the hormone phases which they are 
tested in differ. In Grucza et al. (1997) quasi-FP testing occurred on days 9-10 of the menstrual cycle. In 
contrast, participants in the study by Charkoudian & Johnson (1999) were tested between days 1-7 during 
placebo ingestion, although still coined the quasi-FP. 
ii) Sex Hormones and the Interthreshold Zone 
Despite methodological differences, current knowledge generalizes that during the LP or latter 
active phase, BBT is elevated in non-HC and HC users alike, respectively. Concomitant with this increase 
is an upwards shift in the thresholds for shivering and sweating. The literature does not agree whether 
1 
effector gains decrease or increase, as only some report cold re·sponses diminish, and hot responses 
augment to compensate for higher temperatures. Below (Figure 2.7.) are the replicated ITZ depictions that 
summarize the literature with respect to non-HC users, the ITZ, core shivering (Tcsh'), and core sweating 
(Tcsw') thresholds as a function ofTc throughout the menstrual cycle. 
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Figure 2. 7. The interthreshold zones between the follicular and luteal phases of the menstrual cycle in 
females not using contraceptives. The arrows indicate the alterations to the core temperature thresholds 
for shivering (Tcsh ) and sweating (Tcsw). The dashed arrows depict the sweating and shivering gains 
potentially altered by the menstrual cycle phase status. 
ITZ during the FP ITZ during the LP 
Tcsh' TO·v Tcsh' Tcsw' I I --+ --+ 
.. 
Core temperature Core temperature 
In HC users, phase differences may be dampened though this finding is inconsistent. Below in 
Figure 2.B. are the replicated ITZ depictions that summarize the literature with respect to HC users, the 
ITZ, T csh' and Tcsw' when plotted against Tc throughout the entire menstrual cycle. 
Figure 2.B. The interthreshold zones between the active and withdrawal phases of the menstrual cycle in 
females using contraceptives. The arrows indicate the alterations to the core temperature thresholds for 
shivering (Tcsh) and sweating (Tcsw;.ln hormonal contraceptive (He) users, no marked active phase 
differences in the shivering and sweating gains have been reported. 
ITZ in HC users during the withdrawal phase ITZ in HC users during the active phase 
Tcsh' Tcsw' 
Core temperature Core temperature 
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Rarely are cold and heat stress combined to test the same subject in variable environments. Noting 
how one person responds in both extremes will reduce variability, and better indicate how sex hormones 
affect thermal balance. AB well, He formulae vary not only between studies, but within subjects of a 
single study. Standardizing to one prescription type will render that group as a suitable control. 
However, in order to better comprehend the central mechanism of PRO and OES that most likely 
occurs, it is worthy to monitor the Teas it applies to the ITZ theory. A prior study by Anderson et al. 
(1995) replicated the protocol utilized previously by Mekjavic et al. (1991) to compare central effector 
thresholds between sexes. This model clamps Tsk through a stable water immersion protocol, thus 
removing the peripheral thermoafferents and monitoring solely central sweating and shivering thresholds 
(Mekjavic et aI., 1991). The data found no significant sex differences in the rate of Tc cooling, nor 
sweating and shivering thresholds. Females did exhibit a decreased sweating gain that may be explained 
by sex hormones diminishing central sweat gland activation. More importantly, the females were only 
examined during one phase of the cycle, and thermoregulatory phase alterations disregarded. By utilizing 
a similar protocol wherein females are isolated and monitored throughout both phases of the menstrual 
cycle, fmdings may clarify the role of sex hormones on the central control of thermoregulation. 
8) Summary 
Although most of the literature proposes that OES and PRO affect a thermal set point, no study as 
of yet has utilized a protocol that assures this mechanism, nor indicates whether the width of the ITZ 
changes. The majority find an upwards shift during the LP in the activation thresholds for shivering and 
I 
sweating, and that contraceptives dampen such shifts. On the whole, numerous hypotheses and 
inconsistent findings merit further research to better understand the effects of sex hormones on 
temperature regulation, and to accommodate a population that should be viewed separate from male 
counterparts. 
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Chapter 3- Objective and Hypotheses 
9) Objectives 
Literature suggests fluctuating sex honnones alter thennoregulatory response across the menstrual 
cycle and may account for sex differences to thennal stress. The research does not clarify whether 
honnones affect the central or peripheral thennophysiological pathways, or their integration. Research 
needs to better control core and skin temperatures to ascertain the role of progestogens and oestrogens in 
thennal responses. Therefore, the objectives of this study are to: 
1. Detennine the core thennoeffector thresholds in females using two different measurement 
sites, 
2. Detennine if the core thennoeffector thresholds are altered by the menstrual cycle and/or 
contraceptive use, 
3. Detennine if the thennoeffector gains are altered by the menstrual cycle and/or contraceptive 
use, 
4. Detennine if the width of the core interthreshold zone is altered by the menstrual cycle and/or 
contraceptive use. 
10) Hypotheses 
The hypotheses of this study are: 
1. The thennoeffector thresholds will not be significantly different between the two different 
measurement sites used within a trial, 
2. The core thennoeffector thresholds will increase during the luteal and active phases in non-
contraceptive and contraceptive groups, respectively, 
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3. The sweating gain will be significantly increased, and the shivering gain will be significantly 
decreased during the luteal phase in the non-contraceptive group; however, neither the 
sweating nor shivering gains will be significantly different across the menstrual cycle in the 
contraceptive group, 
4. The width of the core interthreshold zone will not be altered significantly in either group. 
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Chapter 4- Methodology 
11) Participants 
Inclusion criteria: 12 females were recruited based on age (18-40 years), menstrual cycle 
regularity (28-32 days), He use, and body fat content (12-30%). After providing signed informed consent, 
subjects completed the following questionnaires to ensure health status and menstrual cycle normalcy (see 
Appendix 4 and 5): 
• Modified Physical Activity Readiness Questionnaire (Thomas et ai., 1992), and 
• Menstrual history questionnaire. 
Subjects who passed preliminary health screening were divided into two groups: 
• Not using any exogenous contraceptive preparation for at least 3 mo (NeG, n=7) 
• Using the same exogenous monophasic contraceptive preparation for at least 3 mo (ReG, n=5). 
Exclusion criteria: any females that exhibited a potential eating disorder, chronic health condition 
(diabetes, cardiovascular disease, etc.), contraindication to exercise or menstrual dysfunction were 
disqualified from participation. Menstrual cycle dysfunctions included oligomenorrhea (a menstrual cycle 
lasting longer than a 42 days), menorrhagia (greater than 7 days of heavy blood loss during menstruation), 
and amenorrhea (absence of menstruation for 6 months or longer). 
I 
For all trials, subjects were outfitted in a two-piece swim suit, and were requested to avoid 
strenuous exercise, caffeine, and alcohol consumption 24 hr prior. A light meal representative of normal 
diet consumption was allowed approximately 2 hr prior. Subjects provided a urine sample to ensure 
adequate hydration before each trial. Participation for that day was void if urine specific gravity exceeded 
a value of 1.020. 
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12) Experimental Design 
This study required subjects to participate in the following two trials: 
i. Trial! 
The first trial (Trial 1) took place during menstruation or the first week of high hormone dose for 
the NCG and HCG, respectively (days 2-5). Once assigned to the appropriate group, height, weight, body 
composition (as according to Jackson, Pollack and Ward (19S0», and basal l :r02 were measured. Subjects 
donned a Hans Rudolph mask connected to an online gas collection system (Moxus, AEI Technologies) 
and rested for 10 min. The average of the!>' O2 values obtained during min 9-10 was used as the resting 
Ii" O2 for trial 1. Maximal HR was then predicted based on the following regression equation by Tanaka, 
Monahan & Seals (2001), and used to determine the relative workload: 
20S-0.7(age). 
During instrumentation, subjects donned a terry cloth bathrobe and fleece slippers to remain warm 
while clad in only swimsuits. Following set-up and transfer into an immersion tank, subjects underwent 
head out immersion in water maintained at 2S±0.5°C. After a 1 min rest period, subjects performed 
exercise on an underwater cycle ergometer for 20-30 min or until steady-state sweating was achieved 
(Anderson et aI., 1995). The first 10-20 min of exercise was at an intensity of 60-70% of their estimated 
maximal HR, followed by 10 min of intervals alternating 30 sec maximal effort and 30 sec rest. Subjects 
then remained seated on the ergometer in the water until Cr O2 doubled from resting value (Mekjavic et al., 
1991). During cooling in both trials, the water in the tank was continuously agitated to maintain 
convective heat exchange. 
Rectal temperature (Trc), tympanic temperature (Tty), mean skin temperature (T sk), HR, SR, 
relative oxygen consumption (~r 02okg-1), and blood perfusion (PU) were monitored every 30 sec with 
appropriate acquisition software. Thermal comfort and thermal sensation (Cabanac, 1979) were also 
recorded at 5 min intervals. 
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ii. Trial 2 
The second trial (Trial 2) involved identical subject preparation, experimental protocol, and 
measurement collection, however took place 4-7 days following ovulation in the NCG, and during days 
18-21 of the high hormone dose in the RCG. Due to daily influences on basal IT O2, the averageV02value 
was again obtained during min 9-10 rest upon arrival to the laboratory using the same gas collection 
system as trial 1. If a NCG participant experienced an anovulatory cycle (negative ovulation test or PRO 
content <3 J.1g/mL in the LP), both trials 1 and 2 were repeated following the successive menstrual period 
so data was collected from the same menstrual cycle. 
13) Determination of the Menstrual Cycle 
Before data collection, NCG participants tracked the 3 menstrual cycles prior to trial 1 to provide 
investigators an estimated length of the menstrual cycle. These subjects also provided daily urine samples 
that were analyzed for urinary concentrations of hormone metabolites: estrone 3-glucuronide (El G), and 
pregnanediol 3-glucuronide (PdG). From these samples, hormonal profiles of EIG, and PdG were 
determined. Participants were provided with labelled specimen cups to collect the first morning void. 
Subjects temporarily stored samples in the refrigerator (4°C) for no longer than 7 days until delivery to the 
laboratory. Samples were aliquoted and stored at -20°C prior to analysis carried out by immunoassay 
(Munro et aI., 1991). To confmn that ovulation occurred, NCG were provided with ovulation strip kits 
(test strip format, Kurke1 Enterprises, Bellingham, W A). The strips were placed in the urine samples 
beginning on day 12 of the menstrual cycle as instructed in ertch kit. An ovulation test was done until a 
positive result to determine the date for trial 2. 
Participants in the RCG group were not required to track consecutive menstrual cycles or conduct 
ovulation tests, due to consistent menstruation and prevented ovulation. Upon awakening on the 
designated experimental day however, subjects were supplied with two collections cups to sample first 
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morning voids, and brought upon arrival to the laboratory. These were analyzed by the same 
immunoassay for EIG and PdG concentrations. 
14) Measurements 
Immersion tank 
The immersion tank had a diameter of 74" and a height of 60." The water temperature was 
maintained at 28°C using a heater (K-Star, Woodridge, ON) and chiller (A-Struyk, Dunnville, ON) 
accurate to ± O.snC, and continuously stirred by use of a pump (Hayward Super Pump, Oakville, ON). 
Body temperatures 
Participants had Tc measured by Tre and Tty temperatures. Subjects self-inserted a flexible rectal 
probe (Mon-A-Therm Core, Mallinkrodt Medical, St. Louis, USA) 12 cm past the anal sphincter. Tty was 
monitored with a specialized, flexible thermistor (Mallinkrodt Medical, St. Louis, USA) self-inserted into 
the ear canal. The probe was secured using cotton balls strategically placed and adhered with surgical tape 
(3M Transpore Tape, 3M Canada). To measure T sk, 7 heat flow transducers embedded with thermistors 
(FR-025-TH44033-F6, Concept Engineering, Old Saybrook, CT) were securely attached to the skin with 
surgical tape and stretch gauze (Derma Duform Conforming Bandage). T sk was calculated formulating a 
mean of the 7 sites through DasyLab Data Acquisition System Laboratory software (Version 10.0, 
Measurement Computering, Norton, MA) by the following equation according to Hardy & DuBois 
(1938): 
Tsk = 0.07(forehead) + 0.14(forearm) + 0.05(hand) +\0.07(foot) + O.13(shin) + O.l9(quad) + 
0.35( abdomen). 
UsingTsk and Tre, a two-compartment model mean body temperature (Tb) was calculated using 
the following equation, as according to (Lenhardt & Sessler, 2006): 
Tb = x· Tre + (1- x) f sk, so that Tb = 0.64 Tre + 0.36 T sk, 
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where 0.64 = x, and 0.36 := 1 - x. All body temperature measurements were recorded every 30 s 
using a data logger (Smartreader 8 Plus, ACR, Vancouver, Canada) connected to a computer for continual 
monitoring. 
Heart rate 
Subjects were fitted with a heart rate monitor (s81Oi, Polar Electro Oy, Finland) placed around the 
thorax. The electrodes within the plastic transmitter recorded real-time heart rate data from exercise and 
cooling. 
Sweat rate 
A ventilated sweat capsule was firmly attached with Skin Preparation Wipes (Smith and Nephew 
Protective Barrier Wipes) and spirit gum (Graftobian, Madison, WI) to the forehead, on the lateral side of 
the frontal bone to measure local sweat rate (mg-cm-2- min-I). A thin, nylon/spandex toque was also worn 
on the head to ensure local sweating during immersion exercise. SR was determined by quantifying the 
difference in air temperature and density entering and leaving the capsule using a temperature and 
humidity sensor (Omega RX93, Omega Engineering, Stanford, CT). The air entering the capsule was dry 
and of a known, constant volume (Brooks 5850, mass flow controller, Emerson electric, Retfield, PA), 
flowing at a rate of 0.25 L-min-I. 
Oxygen uptake 
V02 and rate of carbon dioxide exhalation was determined from analysis of expired air. The air 
was directed to and analyzed in an online gas collection system (Moxus, AEI Technologies), collected 
breath-by-breath, and averaged over 30 s intervals. 
Skin blood perfosion 
Forehead blood flow was measured using a laser Doppler velocimetry system (Periflux System 
5000, main control unit; PF5010 LDPM, function unit; Perimed, Stockholm, Sweden). The Doppler flow 
meter required calibration using the appropriate Perimed Doppler calibration unit. The small probe (PR 
407 Small Straight Probe, Perimed) was secured to the forehead with surgical tape (3M Transpore Tape, 
3M Canada). The blood flow to the region was expressed in PU and recorded every 30 sec. 
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Urine samples 
To determine urine specific gravity, samples were placed on a refractometer lens (Atago, PAL-
lOS, USA) following calibration using distilled water. 
15) Data Analysis 
The resulting changes from resting Tre and Tty were used for determining the Tcsw', Tcsh' and ITZ 
width. To determine the slopes of the effector responses, SR, V02, and skin blood perfusion were plotted 
against T c. The shivering gains were attained from the linear slope of the line averaging the data 5 min 
pre- and post- shivering threshold (V02/A°e-I ). Sweat gains (SRlA°e- I ) were collected from the data at 
exercise termination until the Tcsw" The intensity of vasomotor activity within the ITZ was averaged and 
expressed as PU/A°e-'. To compare the thermoeffector thresholds and gains within menstrual phase trials 
and between NCG and RCG groups, a 2-way mixed design ANOV A with repeated measures was 
conducted. Significance was reported at a level of P < 0.05. All analyses were performed with SPSS 
statistical software package (Version 16.0). 
Figure 4.1. Throughout cooling, the thresholds for the sweat (SR) and shiver (V02) responses will 
correspond with a core temperature value, thus providing the width of the core interthreshold zone as 
well. The gains of the sweat, shiver and skin blood jlow (PU) responses are also identified, and 
re resented b theta (). 
ITZ 
PU e 
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Figure 4.2. Hypothesizedjluctuations of endogenous and exogenous hormones during one month dose in 
the hormonal contraceptive group (solid lines, HCG) (from Rechichi et al., 2009) or one menstrual cycle 
in the non-contraceptive group (dotted lines, NCG). The HCG withdrawal phase is indicated. Stars denote 
approximate time oftestingfor trials 1 and 2 to better compare progestogen content between groups and 
trials. 
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Chapter 5- Results 
1) Subject demographic profiles 
Table 5.1. summarizes the characteristic data for both groups (NCG, HCG). The NCG 
participants were significantly older than the HCG participants (P<O.05). No other significant differences 
were found in the remaining dependent variables. The means, standard deviation (± SD), and ranges are 
provided. 
Variable 
Table 5.1. Physical characteristics and menstrual cycle lengths for the non-contraceptive (NCG; n=7) and 
hormonal contraceptive (HCG; n=5) groups. t Significantly different from HCG group (P<O.05). 
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2) Hormonal contraceptive type 
Table 5.2. provides the monophasic contraceptive type, and synthetic oestrogen/progestin 
concentrations in each dosage for the RCG. 
Subject code Synthetic oestrogen 
Table 5.2. Individual monophasic contraceptive brand names and synthetic hormonal doses. 
3) Hormonal profiles 
One NCG participant experienced 2 consecutive anovulatory cycles thus was excluded from 
participation. This participant's data is not included in Table 5.1. Three participants (2=1 NCG; n=l RCG) 
performed trial 2 first, then triall due to scheduling restraints. Therefore, the estrone 3-glucuronide (EIG) 
and pregnanediol 3-g1ucuronide (PdG) data were obtained from different, but consecutive menstrual 
1 
cycles. All other participants' hormonal data were analysed from the same menstrual cycle that the trials 
took place. The RCG E1 G and PdG data were assumed constant between trials due to the monophasic 
nature of the contraceptive prescribed. NCG participants collected daily urine samples that were analysed 
in retrospect, beginning from the first or second day of menstruation until trial 2, 4-8 days post-positive 
ovulation. As- expected, the NCG had significantly higher PRO content during trial 2 than trial 1 (P<O.05), 
as well as significantly greater PRO content during trial 2 compared to the HCG (P<O.Ol). Table 5.3. 
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presents the group ElG and PdG data analysed by enzyme immunoassay. The means, and standard 
deviation (± SD) are provided. 
Table 5.3. Number of subjects in parentheses. Basal estrone 3-glucuronide (El G) and pregnanediol 3-
glucuronide (PdG) content from non-contraceptive (NCG) and hormonal contraceptive (RCG) groups. 
Urinary metabolite data was collected on the days of the experiments during both trials. Trial 1 testing for 
NCG took place on days 2-5, and trial 2 testing 4-8 days post-positive ovulation. Tria11 testing for RCG 
took place on days 2-5 of high hormone dose, and days 18-21 of high hormone dose for trial 2. 
tSignificantly different from RCG group (P<O.Ol). *Significantly different from trial 1 (P<0.05). 
4) Core temperature and skin temperature responses 
An independent t-test revealed that basal temperature, all thermoeffector threshold temperatures, 
and cooling rate (trial 2 only) were significantly different between Tre and Tty sites (P<O.OOl). This 
significant finding will be elaborated on in the discussion. Figure 5.1 (A-C) illustrate typical body 
temperature responses from one RCG participant across time. Even though exercise duration varied 
between subjects because of variable sweating responses, thermal responses were relatively similar 
between all subjects (see Appendix). The 2 (phase) x 2 (group) mixed-model ANOYA revealed no 
interaction effect. There were significant differences in basal Tre, but the RCG had significantly lower 
basal Tty (P<O.Ol) regardless of trial (RCG: trial 1 34.60 ± 0.44~, trial 2 34.59 ± 0.27°C; NCG: trial 1 
35.01 ± 0.36°C, trial 2 35.09 ± 0.21°C). In both groups, Tc increased due to exercise as anticipated. The 
magnitude ofTre increase was almost higher (P=O.08) for trial 2. For the NCG, Tre and Tty increased due to 
exercise 0.39 ± 0.29°C and 1.37 ± 0.21 °C respectively for trial 1 , 0.59 ± 0.39°C and 1.39 ± 0.55°C for trial 
2. Presented in the same fashion for the RCG, the increases were 0.43 ± 0.22°C and 1.18 ± 0.82°C, and 
0.69 ± 0.28°C and 1.29 ± 0.42°C. During the cooling portion of the trial, Tre and Tty slowly declined, but 
showed vast inter-individuality. For instance, some participants exhibited greater post-exercise Tre 
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increases than others, due to the response lag of this measurement site (Kenny et ai., 1999). In addition, Tre 
increases concomitant with sweat rate (SR) decreases contributed to variable sweat response gains. 
Overall, only the rate ofTre cooling differed between groups (P<O.OS), with RCG participants cooling 
quicker (trial 1 -1.15 ± 0.43°C, trial 2-1.00 ± O.SO°C) versus NCG participants (trial 1 -0.58 ± 0.22°C, trial 
2 -0.52 ± 0.29°C). Rates of cooling rendered insignificant when measured by Tty. T sk was not significantly 
altered by menstrual phase or group, thus, the intent of the water immersion to stabilizeT sk was achieved. 
A. 
B. 
C. 
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Figures 5.1. Rectal (A), tympanic (B), and mean skin (C) temperatures during exercise and post-exercise 
cooling from one RCG participant. These recordings are representative of all subjects. The black line 
represents the end of exercise. 
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5) Metabolic rate and oxygen consumption 
V O2 and other respiratory measures were obtained to calculate basal metabolism. Results found 
no interaction effect for this dependent variable. There was a trend (P=0.06) for metabolic rate to be 
higher in trial 2. During exercise, if' O2 increased, and then quickly stabilized upon completion. Due to the 
water bath extracting heat energy from the participants' bodies, 1~' O2 increased with the incidence of 
tremors, allowing the core temperature shivering thresholds to be identified (Figure 5.2.). 
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Figure 5.2. Respiratory response due to exercise (0 to 20 min) and cooling (20 to 90 min) from the same 
ReG participant whose data is illustrated in Figure 5.1 (A -C). These recordings are representative of all 
subjects. 
6) Sweat response 
Steady-state sweating was achieved in all individuals due to exercise. As a result of individual 
\ 
variability in SR, some participants required 30 min of bicycling while others only 20 min. Thereafter, SR 
declined after exercise ended until evaporative heat loss terminated completely, and identified the 
cessation threshold (Figure 5.3.). 
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Figure 5.3. Sweat response due to exercise (0 to 20 min) and cooling (20 to 90 min) from the same HeG 
participant whose data is illustrated in Figure 5.1 (A-C). These recordings are representative of all 
subjects. 
7) Thermoeffector thresholds 
The central thermoeffector thresholds were defined at the cessation of sweating, and onset of 
shivering. When the effector activity satisfied threshold criterion, both the absolute and relative changes 
from basal Tre and Tty were analysed. Using the mixed-model ANOVA, there was no interaction effect. 
However, the absolute rectal sweat cessation threshold (Tresw') and relative rectal sweat cessation threshold 
(ilTresw') were significantly greater in trial 2 (P<0.05). At the tympanic site, the absolute sweat cessation 
threshold (Ttysw') was significantly elevated for the NeG versus the HeG (P<0.05), but indifferent 
between trials. With respect to the shiver thresholds, results showed no significant differences between 
I 
groups or within trials (P>0.05) in neither absolute (Tresh,/Ttysh') nor relative (tlTresh,/ilTtysh') shivering 
thresholds. The series of data in Table 5.4. illustrate the central thermoeffector threshold temperatures for 
both groups during the two experiments. 
8) Interthreshold zone widths 
Within the sweat cessation and shivering onset thresholds is the Tc range that maintains 
thermoneutral through changes in vascular tone, coined the interthreshold zone (ITZ). There was no 
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interaction effect for ITZ width. Provided that sweat thresholds were elevated during trial 2, the width of 
the rectal ITZ in this trial was significantly larger (P<0.05). The tympanic ITZ width was nearly different 
between experiments (P=O.l 0), and elicited a significant group main effect (P<0.05), whereby NCG 
participants had a larger gap between effector activity. The series of data in Table 5.4 display the group 
thresholds and ITZs. Following in Figure 5.4. (A-B), the group thresholds and ITZs are depicted in 
vertical bar graphs. Below these, in Figure 5.5. (A-B) and Figure 5.6. (A-B) are a comparison of the 
thermoeffector thresholds and the resultant ITZs between trials in the same RCG participant whose data 
was used in all the above. 
T r • 
Trial 2 37.90 ± 0.46* 37.07 ± 0.45 0.50 ± 0.38* -0.75 ± 0.83 0.82 ± 0.37* 
Table 5.4A. All absolute and relative sweat thresholds (Ttysw,!LlTtysw'), shivering thresholds (Ttysh,!LlTtysh'), 
and interthreshold zones (ITZ) for rectal temperature (Tre) between trials 1 and 2. Data presented as means 
± SD. * Significantly different from FP (P<0.05). 
Ll T tysw' eC) 
Trial 2 35.66 ± 0.87 34.11 ± 0.85 0.80 ± 0.65 -0.75 ± 0.83 1.52 ± 0.84 
Table 5.4B. All absolute and relative sweat thresholds (Ttysw,!LlTtysw'), shivering thresholds (Ttysh,!LlTtysh'), 
and interthreshold zones (ITZ) for tympanic temperature (Tty) between trials 1 and 2. Data presented as 
means± SD. 
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Figure 5.4. Hormonal contraceptive group (ReG) versus non-contraceptive group (NeG) absolute basal 
temperatures, sweat thresholds (Tresw" Ttysw'), and shivering thresholds (Tresh', Ttysh') for both trials. Data 
presented as means ± SD. "* Significantly different from HeG (P<O.05). 
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Figure 5.5B. Interthreshold zone (ITZ) depiction for the rectal temperature (Tre) site during trial 2. These 
recordings are representative of all subjects. 
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9) Thermoeffector gains 
Linear regressions were conducted on thermoeffector activity plotted against changes in Tre and 
Tty. For all participants, the intensity of the SR response was determined using the data obtained between 
exercise termination and sweat cessation. Meanwhile, the intensity of the t, O2 response was determined 
using the data 5 min pre- and 5 min post-shivering onset. The ANOV A results found no significant 
interaction, but a trend (P=0.062), wherein shivering intensity decreased during trial 2 in NCG 
participants, but increased during trial 2 in HCG participants. As well, a near significant phase main effect 
(P=0.10) of a greater SR gain during trial 2 was also noted. 
lO)Forehead blood flow 
During exercise, forehead blood flow (FBF) increased substantially to enable convective and 
conductive heat transfer. During cooling, FBF decreased as a result of vasoconstriction, and preserved T c. 
This typical response is depicted in Figure 5.7. The laser Doppler measurement acquisition and arbitrary 
perfusion units (PU) do not allow absolute measures ofFBF to be quantified. Instead, the linear decrease 
in FBF from sweat cessation to shiver onset was determined using regression, and provided the intensity 
of vasomotor tone required to maintain thermoneutraul within the ITZ. There was no interaction effect. As 
well, the declination slope of FBF throughout time was not statistically different, but drifted towards 
significance by both group (P=0.17), and phase (P=O.l 0). The HCG exhibited greater FBF gain versus the 
NCG, while the change in vasomotor tone was greater during cooling in trial 2. 
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Figure 5.7. Blood flow response due to cooling after exercise (20 to 90 min) from the same RCG 
participant whose data is illustrated in Figure 5.1 (A-C). These recordings are representative of all 
subjects. 
U)Triallength and thermal votes 
Even though Tre cooling rates varied between groups, the total length of water immersion was 
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insignificantly different (P>0.05), and there was no interaction effect. During triall, the trial lengths were 
slightly longer, yet not statistically (P=0.19). The subjective measures at the time of shivering were not 
significantly altered due to menstrual phase (P>0.05), but TC was (P<0.05), and TS nearly (P=0.093) 
statistically different between groups. RCG participants perceived the cold stress as significantly less 
comfortable, and made them closer to unbearably cold. The TC and TS votes are illustrated below in 
Figure 5.B. in attempt to quantify whole body thermal "pleasur~" and "comfort level" throughout cooling. 
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Figure 5.8. Hormonal contraceptive group (HCG) versus non-contraceptive group (NCG) thermal comfort 
(TC) and thermal sensation (TS). * Significantly different from HCG (P<0.05). 
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Chapter 6- Discussion 
In the present study, the major findings were that in both groups, basal body temperature was 
unchanged pre- versus post-ovulation. However, the central sweat cessation threshold was elevated during 
trial 2 when measured at the rectal temperature site. As a result, the width of the ITZ between sweating 
and shivering thresholds was larger with respect to Treonly. The HCG cooled more quickly post-exercise 
compared to the NCG, and elicited a narrower ITZ when measured at the tympanic temperature site. In 
addition, the 2 different sites that measured Tc were not similar, providing inconsistent differences in the 
thermal variables depending on which site was utilized. 
Previous studies suggest that BBT increases approximately 0.3-0SC (Kolka & Stephenson, 1989; 
Frascarolo et ai., 1990) post-ovulation due to a rise in PRO concentration (Hessemer & Bruck, 1985; 
Kolka & Stephenson, 1989), though the mechanism linking the two events remain unclear. In 
anaesthetized animals, PRO caused the discharge rate of cold-sensitive neurons in the hypothalamus to 
increase (Nakayama et ai., 1975); thus, activation of these neurons initiates cold thermoeffector responses 
and may increase BBT. To add to the ambiguity, other mechanisms include increased non-shivering 
thermogenesis due to an elevated basal metabolic rate or an infection-inducing role of PRO that increases 
interleukin-l secretion from immune cells (Cannon & Dinarello, 1985; Saladin, 2001). Against the general 
consensus, subjects in either group did not display a significant change in BBT throughout trials. One 
could argue that the NCG participants were anovulatory, but L~ surge detection kits were provided, and 
all participants provided positive test results. When BBT is increased post-ovulation, it is known as a 
biphasic pattern; however, some women ovulate without this distinct BBT change to create a monophasic 
pattern (Barron & Fehring, 2005). Inspection of the data shows that out of all 7 ovulating NCG 
participants, only 2 elicited biphasic patterns. This is further supported by pilot BBT collection over 2 
consecutive menstrual cycles (n=3) that did not detect mid-cycle BBT increases (data not shown). 2 HCG 
participants also exhibited biphasic patterns, as the natural tendency of the menstrual cycle overrides even 
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though ovulation is prevented (Grucza et aI., 1997). There are many factors known to affect BBT-
alcohol consumption, late hours of wakefulness, oversleeping, travel, time zones, stress, illness, and 
medications-many of which were controlled as best possible, but cannot be ruled out entirely. Even more 
so, Barron & Fehring (2005) stated that BBT is not completely accurate in predicting ovulation. An 
increase in BBT along with the occurrence of ovulation was only 22.1 % accurate, while urinary LH 
concentration or OES:PRO ratios were approximately 93% accurate. Previous authors report the 
magnitude of change in BBT is greatest between the hours of 0300h-0500h (Hessemer & Bruck, 1985), 
and elicit a circadian rhythm (Cagnacci et aI., 2002). The peak amplitude can easily be missed with only a 
single measurement. It was not logistically feasible to have participants in the laboratory at such hours, 
and scheduling restraints caused the trials to take place at various times of the day between subjects. 
Within individual subjects however, trials took place no more than 1.5 hours difference between, and 
therefore circadian influences were not likely the cause. So while an increase in BBT seems to be 
characteristic for menstrual cycle research, it is neither a consistent nor entirely reliable fmding. 
The subsequent major findings of this study were inconsistent thermo effector threshold and gain 
alterations. Only ~Tresw' and Tresw' were elevated during trial 2, with a trend for increased sweating gain. 
These findings agree with others (Gonzalez et aI., 2002; Hessemer & Bruck, 1985; Kolka & Stephenson, 
1989), yet contradict those reporting an elevated shivering threshold, and decreased shivering gain 
(Hessemer & Bruck, 1985; Grucza et al., 1997; Gonzalelz & Blanchard, 1989). Concomitant shifts in BBT 
and both thermoeffector threshold temperatures indicated an altered central oscillator with changes in sex 
hormone concentrations (Stephenson & Kolka, 1985). However~ because shivering was not similarly 
affected, central control is unlikely modified. Instead, different mechanisms might occur during hot and 
cold stresses or in previous literature, the mechanism for a modified cold response was actually peripheral. 
A peripheral cold mechanism is probable with findings such that cutaneous thermal conductance 
decreased in the LP during 90 minute exposure to 28°C air (Frascarolo et al. 1990). Heat transfer to the 
periphery was minimized, and insulation provided by the shell increased. Skin sensitivity to the cold was 
enhanced in the LP and during PRO administration at the beginning of the cycle to mimic ovulation 
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(Kenshalo, 1966). Even though the cold effectors are innervated by efferent messages received from the 
central nervous system, the efferents and perception of thermal stimuli first depend on afferents from 
peripheral thermoreceptors (Saladin, 2001). Fluctuating PRO and OES content may directly influence 
depolarization of peripheral cold-sensitive receptors, although difficult to determine. Early animal studies 
indicated thermal information responding to cold stimulus was delivered only from receptors in the 
periphery (Simon, 1972). Few are located deeper in the body, unlike those that are warm-sensitive. 
Furthermore, a study conducted on female monkeys throughout the estrous cycle found smooth muscle 
that was transplanted into the primates constricted to different diameters, independent of nervous system 
communication but dependent on hormonal content ([Nafe, 1934], as referenced by Kenshalo, 1966). It is 
evident that while a greater concentration of PRO is in circulation, neuronal stimulation of the peripheral 
cold receptors is altered, and cold effector activity is affected in return. Shell variability was minimized in 
the present protocol to remove the variability of afferents from the cold thermoreceptors. Given that cold 
receptors are located predominantly in the periphery and significant phase differences were not found after 
removal of their influence, the mechanism responsible for menstrual phase adjustments during cold stress 
is superficial. 
On the other hand, given that sweating thresholds were different and the peripheral drive was 
essentially equal between phases, the menstrual cycle alterations during heat stress are likely central in 
origin. Previous literature found that greater PRO concentration decreased stimulation of the warm-
sensitive neurons in rats (Nakayama et al., 1975). It is conceivable that with increased PRO, 
depolarization of warm-sensitive neurons in the hypothalamus is attenuated or perturbed, and interrupts 
the efferents responsible for sweat gland stimulation. After all, neuronal depolarization is dependent not 
only on the synapses it directly receives; neurons located elsewhere in the nervous system, and the 
sensitivity of the neurons that integrate afferent information also affect the delivery of efferent 
transduction (Simon, 2000). Complicated feedback loops are created between the numbers of PRO 
receptor-complexes formed in target cells, and the thermoregulatory control ofthe hypothalamus 
(Thagard, 2002). Furthermore, thermoreceptors located in the spinal cords of rats and felines responded 
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only to heating, and minimally to cooling. Meanwhile, those located in the periphery were less influenced 
by warming (Simon, 1972). This shows that the drive for heat loss is dominated by a central component, 
thus subject to hormonal influence in this experiment. Of course this mechanism cannot be assured as 
findings require extrapolation from animal populations while no human data exist. Nonetheless, since a 
central component is more influential on heat loss responses and central drive was emphasized in the 
present protocol, the sweating threshold changed significantly. The varying concentrations of PRO modify 
the sweating threshold and gain because the hormonal adjustment during heat stress and physiological 
need for sweating are both centrally occurring. 
Only one other study to our knowledge has examined the same individuals in variable thermal 
stress throughout the menstrual cycle. This classic study by Hessemer & Bruck (1985) was pivotal in 
justifying the altered set-point hypothesis because hot and cold responses were affected equally. Below in 
Table 6.1., data is illustrated from each to compare thermal responses between studies in each trials. 
Basal body temperature 
Basal metabolic rate 
Sweating cessation core temperature 
threshold 
Shivering onset core temperature 
threshold 
Sweating gain 
Shivering gain 
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Table 6.1. A comparison of dependent variables in the only two studies examining the same participants in 
both heat and cold stress throughout the menstrual cycle. (NS = not significant; t = increased). 
As evident in the table, there are controversies between studies. They likely result from methodology. In 
Hessemer & Bruck (1985) hot air was increased from l8-58°C for 12-15 minutes until sweating, and cold 
air was rrunped from 18°C at -1 °C°min-1 until shivering. From these hot and cold tests, more variables 
were found different between phases, than in the present experiment. Although more significant phase 
differences in the other study may stem from disparate testing schedules, they could be consequences of 
extreme air temperatures, and more mild changes in Te. Below is another table (Table 6.2.) to compare the 
same studies, however examine ilTe at the thermoeffector thresholds. (Note: the effector responses were 
quantified very similar-shivering with V02, and sweating by calculating change in water vapour over a 
local site). 
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Response 
Table 6.2. A comparison of relative changes in rectal (Tro) and tympanic (Tty) core temperatures following 
varied methods of heating and cooling to the participants in both heat and cold stress throughout the 
menstrual cycle. 
In Hessemer & Bruck (1985), the ambient temperatures were severe, and delivered in a dynamic fashion. 
Exposure time was less, and disallowed To to change drastically before thermoeffector activation. 
Therefore, the drive for sweating and shivering was most likely from T sk changing so rapidly, and thermal 
afferents were delivered from peripheral receptors only. In comparison, the rationale for utilizing stable 
water immersion was to isolate the central drive, remove dynamic changes in Tsk, and provide a gradual, 
uniform thermal stress to the core. This experiment established that the cold response drive-proven to be 
more peripheral-is altered by fluctuating hormones when central thermoregulation is not targeted. 
Conversely, the heat response drive-which is more central-is'altered by different hormonal 
concentrations whilst central thermal control is isolated. This experiment verifies that fluctuating PRO and 
OES affect thermoeffector activity by modulating only the component driving the thermoregulatory 
response. The contribution of the periphery and core is different for heat production and heat loss, 
especially when L1Tc is larger than O.15°C (Stephenson & Kolka, 1989). As a result, the sex hormones 
adjust thermal response through temperature-distinct means. So far, although the lack of a biphasic BBT 
pattern suggests that female research does not need to be menstrual cycle specific, the latter discussion 
states otherwise. The thresholds and intensities of thermal responses are altered despite a deficient BBT 
increase post-ovulation. 
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Provided that the T resw' and 11 T resw' were greater in trial 2, the width of the rectal ITZ was also 
influenced by menstrual phase. However, the resultant ITZ was skewed, wherein only the heat loss 
threshold widened the zone. Although it was not a primary goal of the study, these findings confirm the 
presence of an ITZ-Tc range which neither sweating nor shivering occur-and contradict the set-point 
theory (Hammel et al., 1968). Therefore, it is difficult to follow suit with the shifted set-point hypothesis 
when a reference temperature was not evident. In this study, the minimum ITZ width was O.63°C (Tre) 
(Table 5.4 A-B). A O.63°C change is far greater than the magnitude corresponding with a set-point. When 
Cabanac & Massonet (1977) tested the set-point theory, they found oesophageal temperature sweating and 
shivering thresholds were separated by a mere O.05°C. Again, it was not the purpose of this experiment to 
support or negate a particular thermoregulatory model; however, the absence of a reference temperature 
does not support the most accepted hypothesis that the set-point temperature is elevated during trial 2. 
Furthermore, future research should calculate heat storage across the menstrual cycle as an alternative 
hypothesis. Rather than using temperature as the regulated variable, heat balance can be monitored to 
determine a critical temperature versus a critical heat balance that the menstrual cycle may alter. 
Other interesting findings were the differences between the HCG and NCG. The significant age 
discrepancy is not surprising. This reflects the prevalence of younger females who choose to utilize HCs 
based on lifestyle choices and marital status. The HCG was recl1;Uited based on the monophasic 
contraceptive. The steady hormonal dose was to serve these participants as controls. They were tested at 
two different times during the active dose. Unlike previous studies that examine contraceptive users 
during menses (placebo), those in this study were observed in the week following menstruation. Stable 
PRO and OES concentrations were hypothesized to eradicate alterations between phases, but demonstrate 
differences between groups. Irrespective of trial, the HCG illustrated a decreased tympanic sweating 
threshold, and a narrower ITZ width. This suggests that thermal sweating is enhanced with contraceptive 
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use. The presence of exogenous progestin may increase sweat sensitivity during heating. The natural and 
synthetic forms differ by their chemical structure and potency, making the endogenous hormone less 
powerful (F erin et aI, 1993). SP consists of a compound that is similar to testosterone, thus its effects are 
androgenic (Ferin et aI., 1993). Given that men have greater and earlier sudomotor output (Bittel & 
Henane, 1975), this could explain the decreased Ttysw' in the HCG. In addition, thermal gains were not 
significantly different between groups, but Tre cooling rate was significantly faster in the HCG. As a 
result, the votes on subjective thermal scales were closer to "extremely uncomfortable," and "unbearably 
cold." It is well known that Tc cooling rate is highly dependent on body mass and subcutaneous tissue 
adiposity (Anderson, 1999). But as seen in Table 5.1, group demographics were not different, and could 
not account for a faster cooling rate. Unfortunately, few have examined cold responses in females utilizing 
HCs. A study by Grucza et al. (1997) exposed contraceptive users to cold air (3.4°C) for 30 minutes. Tre 
cooling rate was similar between phases, and near the same rate in the present study, approximately 
1.l0°C·hr-1• In comparison, the Tre cooling rate ofnon-HC users in a study by Tikuisis et al. (2000) was 
only 0.45°C·hr-1 while immersed in 18°C water. Perhaps synthetic hormones enhance heat extraction or 
exaggerate autonomic response during temperature stress. Participants in this experiment also elicited a 
substantially greater blood flow gain. This further indicates a more intense reaction to preserve heat. 
Taken together, the perception, and physiology of heat and cold extremes are more stressful in females 
that use HCs; sweating occurs earlier, vascular changes are greater, core cooling is quicker, and subjective 
comfort is less bearable while cooling. Unfortunately thermal response is not yet thoroughly examined in 
HCG users, leaving little research to contrast these females to non-user counterparts. 
Another unexpected finding in the present study was significantly different basal and threshold 
temperatures between the tympanic and rectal sites. Oesophageal temperature would have provided a third 
and potentially more accurate representation ofTc (Moran & Mendal, 2000). However due to limitations, 
only Tre and Tty were used. The following describes possible reasons for disparate measurements, as 
reviewed in detail by Moran & Mendal (2000). The tympanic membrane is contiguous with the vessels 
supplying the carotid artery, and ultimately the hypothalamus. Although seemingly flawless, dirt, insertion 
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depth, rapid head movement, or examiner skill can affect the accuracy of this measure. The experimenters 
described the insertion procedure equally to each participant, and gave best efforts to not reposition the 
thermometer when securing it. Despite this care, Tty measurements were consistently lower than those of 
Tre• This finding however, is not uncommon according to the review article, and others (Bittel & Henane, 
1975). Tre is considered most practical, produces an "average" core temperature, but is usually higher than 
other sites due to the proximity of viscera. Unfortunately, insertion depth can influence its accuracy, and 
because the thermal inertia of surrounding tissue is large, the response time lags. This delay was evident 
by the unanticipated direction of the sweating gain slope when plotted against ATre• Overall, future 
investigation and comparisons should avoid using Tty when Tre is available. Even still, oesophageal 
temperature is preferred due to a quicker response, and proximity to the blood leaving the aorta (Moran & 
Menda1, 2002). Ifbetween-study comparisons are being made, authors must evaluate the same anatomical 
location because of variability within the sites. 
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Chapter 7- Conclusions 
1) Conclusions 
Within the limits of the present experiment, it is concluded that: 
1. An increase in basal body temperature during the luteal phase may not always be a marked 
physiological response in women, nor serve as an accurate indicator of ovulation consistently. 
2. Quantifying thermoeffector thresholds with both tympanic and rectal temperatures provides 
remarkably different values within one trial. As a consequence, caution must be used when 
comparing core temperature between studies, and avoid using tympanic temperature alone, as 
results will be inaccurately low. 
3. The central sweating threshold increases during the latter half of the menstrual cycle for both 
non-users and users of hormonal contraceptives. Between these populations however, 
hormonal contraceptive users display an overall decrease in the sweating threshold, 
irrespective of hormonal dose phase. 
4. Sweating gain substantially increases during the latter half of the menstrual cycle for both 
non-users and users of hormonal contraceptives. However, shivering gain is unchanged 
throughout for either group. 
5. The width of the interthreshold zone increases during the latter half of the menstrual cycle, 
due to an increase in the heat loss thermoeffector tht;eshold. In addition, a decrease in the 
sweat threshold in hormonal contraceptive users decreases the width of the tympanic 
temperature interthreshold zone regardless of hormonal dose phase .. 
2) The direction for future research 
The present study isolated central thermoregulatory control to establish the role of female sex 
hormones on central thermoeffector threshold temperatures, and width of the ITZ. Data shows the 
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extent of alterations depends on whether the drive for heat loss or production is central or peripheral. 
An interesting study can involve using this same protocol, but examine females with menstrual cycle 
disorders, such as amenorrhea or luteal phase deficiency (not enough circulating PRO). Thermal 
response may remain unchanged between phases when endogenous hormone concentrations are 
abnormally low, and support a critical level of PRO is required for thermal modifications. A 
longitudinal study that investigates females throughout the menstrual cycle before, and then 3 months 
after administering a HC, would also broaden understanding. Testing participants with a standardized 
protocol before and after HC use will better indicate if thermal sensitivity changes with exogenous 
hormones. Furthermore, to verify an increase in BBT during the LP, Tc can be monitored constantly 
using telemetry pills or continuous Trcmeasurement. Temperature can be recorded for 24 hours, every 
day throughout consecutive menstrual cycles for more vivid understanding. Even more so, to better 
understand the mechanisms of this potential shift in basal temperature, plasma cytokines may be 
quantified daily for consecutive cycles to prove or disprove the hypothesis of the LP fever-like state 
(Cannon & Dinarello, 1985). An alternative study could quantify an ambient temperature that is 
"preferred" for the whole-body pre- versus post-ovulation. This may determine whether peripheral 
thermal conductance is altered, and the peripheral mechanism hypothesized to alter BBT (Frascarolo 
et aI., 1990). The effects ofthe menstrual cycle on overall heat storage would also be valuable to 
investigate. Finally, if sweating is induced locally via a pharmacological substance as opposed to 
whole-body heating-such as pilocarpine-whether PRO influences only the central drive for heat 
loss versus the peripheral stimulation of the sweat gland can be verified. 
More generally speaking, future research should standardize Tc with the use ofliquid conditioning 
garments or water immersion before exposure to thermal stress. Entering a given environment with 
the same T c in both menstrual phases will provide a better understanding of hOlIDonal influences on 
the peripheral organs involved in thermoregulation. Likewise, skin temperature can be clamped, like 
in this experiment, to improve understanding of the effects on central thermoregulation. Targeting 
either the core or shell helps to define the mechanisms of the female sex hormones on each of these 
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thermoregulatory components. Ideally the responses to cold and heat challenges should be 
investigated in the same participant to reduce inter-individuality, and provide more data to compare 
with the present experiment and Hessemer & Bruck (1985). As well, studies that involve both cold 
and heat challenges will better support or negate an altered central controller with increasing PRO. In 
participants not utilizing hormonal contraceptives, the occurrence of ovulation should coincide with a 
positive luteinizing hormone test or quantification of sex hormones, as BBT is not sufficient according 
to the present data. Finally, the effects of hormonal contraceptive use have yielded controversial data, 
and participants utilizing them should be examined as frequently as non-users, due to their prevalence 
in healthily ovulating, and amenorrheic females. 
3) Limitations 
This study was predicated on the hypothesis that thermoregulation occurs through the "reciprocal 
inhibition" temperature model. Another temperature model is the "set-point." In both these models, 
temperature is the regulated variable. In other words, the temperature value(s) which the body is 
sensed to be at will dictate the activation and intensity of the thermal effectors. However, there is 
another model called the "heat storage" model, wherein temperature is not the controlled variable. 
Instead, thermoregulation is achieved by sensing the amount of heat storage, and balancing heat gain 
with heat loss. Heat storage is not calculated with varying temperatures, but with dry and wet heat loss 
terms found in the heat balance equation. Consequently, future analysis should take into consideration 
the third and final human thermoregulatory model to further clarify the role of female sex hormones 
I 
on thermoregulation. 
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Appendices 
Glossary of Important Terms 
17ft-OESTRADIOL2: A natural estrogenic hormone that is a phenolic alcohol ofC18H2402 secreted 
chiefly by the ovaries, is the most potent of the naturally occurring oestrogens, and is administered in its 
natural or semisynthetic esterified form especially to treat menopausal symptoms. 
84 
CRITICAL TEMPERATURE, LOWER}: The ambient temperature below which the rate of metabolic heat 
production of a resting thermoregulating animal must be increased by shivering and/or nonshivering 
thermogenesis in order to maintain thermal balance. 
CRITICAL TEMPERATURE, UPPER}: The ambient temperature above which the rate of evaporative heat 
loss of a resting thermoregulating animal must be increased (e.g., by thermal tachypnea or by thermal 
sweating) in order to maintain thermal balance. 
PROGESTERONE2: A female steroid sex hormone C2I H300 2 that is secreted by the corpus luteum to 
prepare the endometrium for implantation and later by the placenta during pregnancy to prevent rejection 
of the developing embryo or fetus; also: a synthetic steroid resembling progesterone in action. 
THERMAL NEUTRAL ZONE (TNZ) }: The range of ambient temperature at which temperature regulation 
is achieved only by control of sensible heat loss, i.e., without regulatory changes in metabolic heat 
production or evaporative heat loss. 
THERMOEFFECTOR]: An organ system and its action, respectively, that affect heat balance in a 
controlled manner as part of the processes of temperature regulation. 
THERMOEFFECTOR GAINl : The derivative of the thermoeffector output with respect to body 
temperature deviation from the set-point. 
THERMOEFFECTOR THRESHOLD]: The level of activity of a potential thermoeffector that is 
transgressed when it becomes actively involved in temperature regulation. The thresholds of other 
thermoeffectors are arbitrarily defined, or agreed upon by convention, because basal or resting levels are 
difficult to define, e.g., in case of circulatory convection of heat to the skin and the underlying cutaneous 
vasomotor tone. 
1 
THERMOEFFECTOR THRESHOLD TEMPERA TURE l : Describes the level of a specified body 
temperature (e.g., core temperature or mean body temperature) the transgression of which in one direction, 
either upward or downward, will activate a certain thermoeffector. As a rule, the threshold core 
temperature determined for a given effector will be a function of skin temperature, and vice versa. 
THERMOEFFECTOR THRESHOLD ZONE (INTERTHRESHOLD ZONE)}: The temperature range 
between two threshold (body) temperatures, for activation of any thermoeffector responses, particularly of 
metabolic heat production and of evaporative heat loss when no thermal load is present. This special 
steady-state may be called set-point. 
Definitions obtained from: 
1 IUPS Thennal Commission. (2001). Glossary of tenns for thennal physiology, 3rd ed. Japanese Journal of Physiology, 51, 245-
280. 
2Merriam-Webster's Medical Desk Dictionary. (2005). Retrieved Jun 5, 2009, from http://merriam-webster.comlmedical. 
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Thermal Comfort Vote 
1. Comfortable 
1.5 
2 Slightly uncomfortable 
2.5 
3. Uncomfortable 
3.5 
4. Very uncomfortable 
4.5 
5. Extremely uncomfortable 
Thermal Sensation Scale 
0 unbearably cold 
1 very cold 
2 cold 
3 cool 
4 slightly cool 
5 neutral 
6 slightly wann 
7 wann 
8 hot 
9 very hot 
10 unbearably hot 
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Informed Consent: EEL-OS3 
Project Title: The effect of the menstrual cycle and oral contraceptive use on central 
thermoeffector threshold temperatures and the interthreshold zone width. 
Principal Investigator: 
Dr. Stephen Cheung, Ph.D. (Associate Professor) 
Department of Physical Education and Kinesiology 
Brock University 
905-688-5550 x 5662, stephen.cheung@brocku.ca 
INVITATION 
Principal Student Investigator 
Ms. Natalie Dies (M.Sc. Candidate) 
Department of Physical Education and Kinesiology 
Brock University 
289-668-0771, nat.dies@brocku.ca 
You are invited to participate in a study that involves research. The purpose of this study is to examine 
how natural and synthetic female sex hormones affect the core temperature shivering and sweating 
thresholds. Whether the oestrogens and progestogens that fluctuate throughout the menstrual cycle affect 
the central activation of thermal responses is unknown. As well, whether monophasic contraceptives alter 
when you shiver or sweat has yet to be determined. The shivering and sweating core temperature threshold 
measurements will give us information on how the hormones affect the thermoregulatory system, and may 
benefit females in many settings, including athletes or industrial employees. 
WHAT'S INVOLVED 
The first testing session will occur during the early follicular phase of the menstrual cycle (days 2-5), and 
the second testing session will occur during the late luteal phase of the menstrual cycle (4-8 days post-
ovulation, or days 18-22 if you are prescribed a contraceptive). Time commitment will be approximately 8 
hours over the two sessions, spaced out over one menstrual cycle. In addition, you will be asked to refrain 
from alcohol and/or heavy exercise for 24 hours prior to the trial, and caffeine on the day of the trial. You 
will be wearing a bathing suit for all the sessions, and will have access to change rooms for you to change 
into the required clothing. 
In the first session, your height, weight, and amount of body fat will be measured. Body fat testing will be 
performed using skinfold calipers, which might cause a slight pinching sensation, and will be taken by 
someone of the same sex in a private room. You will receive a treatment of pilocarpine iontophoresis 
while seated. The drug is housed within two specially designed electrodes that are securely attached to 
your forearm. An electrical current flows through the electrod~s to allow the drug to perfuse through your 
skin and stimulate the sweat glands under the area of the electrodes. The electrical current is of very low 
amperage, and mayor may not provide a sensation similar to that of "pins and needles." Following 5 
minutes of the drug delivery, specially designed sweat collection tubing will be attached to your forearm 
where the sweat was produced. Within 20 minutes, the sweat collection tubing will be removed and 
analyzed for the amount of sweat produced and its tonicity. After this seated measurement, you will 
perform 30 minutes of underwater exercise at an intensity of 50% of the estimated maximal heart rate 
based on your age. Depending on how much sweat is produced on your forehead, the exercise may last 
slightly less or longer than this estimated time. The exercise condition will involve pedaling on a bike 
immersed in water that is level to the underarms, and at a comfortable 28°C. Following this exercise, you 
will remain seated in the water, but only to rest. You will remain seated until you are shivering steadily. 
During both sessions, your internal temperature will be measured by wearing temperature sensors in the 
rectum and tympanic membrane. The rectal sensor consists of a very thin and flexible plastic tube that you 
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insert 15 cm beyond the anus. The tympanic sensor is a specially designed tube with a valve at the end, to 
keep the probe in place once you insert in your ear canal close to touching the membrane. Placed on your 
forehead will be a plastic sweat capsule that will collect the rate at which you are sweating at that site. 
Near the sweat capsule will be a laser Doppler probe that will determine the rate of blood flow at the 
forehead. You will have your heart rate monitored using a sensor in a flexible strap around the chest. Skin 
temperature and heat flow will be monitored using wires taped to various sites on your body. Your oxygen 
uptake will be measured by having you breathe through a soft silicone mask. You will also be asked at 
different times to give your subjective feeling of your effort and also your thermal sensation and comfort. 
A technician of the same sex will be available to assist with the dressing and instrumentation. The sessions 
will take about 3.5 hours. The first session will occur pre-ovulation, while the second will occur "post-
ovulation," or during the high hormone dosage offemales using a contraceptive. 
POTENTIAL BENEFITS AND RISKS 
Possible benefits of participation include your receiving a body composition that is a quantification of 
your lean body mass. The fitness test will help you understand your fitness level and the intensity that best 
suits you for general exercise training. This study will also provide information on how your menstrual 
cycle and the fluctuating estrogens and progestogens alter your body's autonomic ability to regulate 
temperature. 
There also may be risks associated with participation. The nature of underwater exercise may leave your 
muscles feeling quite tired for up to 24 hours after the test and experimental sessions. There is a very 
remote risk of heart attack or stroke when exercising or cooling in the water, but this is minimized with 
the use of the health screening questionnaire. There will be at least two investigators trained in First Aid 
and CPR present for each experiment. 
Experimental sessions will be terminated if: 
1. Rectal temperature increases beyond 39.SoC. 
2. Rectal temperature decreases beyond 36.0°C 
3. Heart rate has risen above 95% of its maximum (220-age) for 3 min. 
4. Dizziness or nausea precludes further experimentation. 
5. Subject decides, for any reason, to end the experiment. 
6. The investigators determine that the subject cannot tolerate the thermal stress in order to continue. 
If you experience any unusual symptoms after completing a testing session, you should immediately seek 
medical attention and inform Dr. Cheung and Natalie Dies. The investigators will also contact you the 
evening of your participation to ensure that you are in a healthy state. Depending on your health status, 
you may be asked to consult with a physician. 
1 
Insertion of the flexible rectal probe may cause slight discomfort. You will be given instruction about how 
to prepare the probe, and will self-insert the probe in a private room. You will be provided with water-
based lubricant if necessary, and will secure the probe with a soft gauze "sumo sling" harness which will 
keep it in place during exercise. Insertion of the flexible tympanic probe may cause slight discomfort and 
cause you to hear a constant humming noise. The probe is specially designed with a valve-like system to 
prevent the probe from perforating your tympanic membrane. You will insert it into the auditory canal 
until it touches the membrane. The probe is then withdrawn slightly to alleviate any initial discomfort. The 
probe and ear are then covered with a soft, circular foam pad that is gently secured to the head with a 
strap. There is a slight but real risk of perforations to the bowel from the insertion of the rectal probe, and 
the tympanic membrane from the insertion of the tympanic probe, though the investigators are unaware of 
these occurring in a research setting. 
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Some of the symptoms that may be experienced with a decreased body temperature include: discomfort, 
pain, fatigue, shivering, loss of fine motor coordination, minor mental confusion and irritability. These 
symptoms, except for fatigue like that from mild exercise, commonly disappear almost immediately upon 
return to normal body temperature. Some of the symptoms that may be experienced with an elevated body 
temperature include: discomfort, sweating, flushing and redness in the face and body, thirst, loss of fine 
motor coordination due to sweating, minor mental confusion, dizziness or nausea. These symptoms, 
except for thirst, commonly disappear almost immediately upon return to normal body temperature. You 
will be given as much fluid as desired at the end of the experiment. You will be asked to stay in the lab for 
45-60 min following each experiment, and your core temperature, heart rate, blood pressure, and 
hydration status will be monitored. 
RECTAL PROBES 
When performed in a healthcare setting, insertion of the rectal probe is a controlled act as set out in the 
Regulated Health Professions ACT. While this act does not extend to research outside of a healthcare 
setting, you should be aware of the following potential risks: 
• Insertion of the rectal probe can stimulate the vagus nerve which can cause slowing of the heart 
rate which may lead to fainting. This is more likely to happen if you have a low resting heart rate. 
• Perforation of the bowel can lead to peritonitis, a serious infection of the abdominal cavity. 
• You should not participate in this research if you are pregnant, diabetic, have a history of 
esophageal problems (including reflux esophagitis), are under the influence of alcohol or other 
sedating substances (tranquilizers, sleeping pills, street drugs) or have any history of fainting or 
heart disease. 
CONFIDENTIALITY 
Access to this data will be restricted to Dr. Cheung, Ms. Natalie Dies, Mr. Raffy Dotan (research 
technician), Mr. Shane Kilburn, Mr. Geoff Hartley, Mr. Matthew Smith, Ms. Nikki Zouros, Ms. Leah 
Rosso (research assistants). Your participation will remain confidential. The data collected from this 
investigation will be kept secured on the premises of the Department of Physical Education and 
Kinesiology (PEKN) at Brock University in Dr. Cheung's office or laboratory, and will not be accessed by 
anyone other than the listed investigators. The data (paper and electronic) will be destroyed five years 
after the publication of the results of the study. 
Investigators will require disclosure of your name and contact information (phone, email), and therefore 
your participation is not anonymous during the conduct of the research. All participants will have their 
names removed from any data. The master list matching participants to data will be kept by Natalie Dies, 
and will be destroyed following the publication of data. All information you provide is considered 
confidential; your name will not be included or, in any other w.,.y, associated with the data collected in the 
study. Furthermore, because our interest is in the average responses of the entire group of participants, you 
will not be identified individually in any way in written reports of this research. 
VOLUNTARY PARTICIPATION 
Participation in this study is voluntary. If you wish, you may decline to answer any questions or 
participate in any component of the study. Further, you may decide to withdraw from this study at any 
time and may do so without any penalty or loss of benefits to which you are entitled. Participation, non-
participation, or withdrawal from the study will not affect your standing at Brock University. 
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PUBLICATION OF RESULTS 
Results of this study may be published in professional journals and presented at conferences, but your 
personal information and participation will remain confidential. Approximately one month after we finish 
testing all participants, we will provide you with a summary of your own results and also the overall group 
results. Feedback about this study will be available from Natalie Dies (nat.dies@brocku.ca, 289-668-
0771). 
CONTACT INFORMATION AND ETHICS CLEARANCE 
If you have any questions about this study or require further information, please contact the Principal 
Investigator using the contact information provided above. This study has been reviewed and received 
ethics clearance through the Research Ethics Board at Brock University REB 08-058. If you have any 
comments or concerns about your rights as a research participant, please contact the Research Ethics 
Office at (905) 688-5550 Ext. 3035, reb@brocku.ca. 
CONSENT FORM 
I agree to participate in this study described above. I have made this decision based on the information I 
have read in the Information-Consent Letter. I have had the opportunity to receive any additional details I 
wanted about the study and understand that I may ask questions in the future. I understand that I may 
withdraw this consent at any time. My participation, non-participation, or withdrawal from the study will 
not affect my standing at Brock University. 
Name: 
------------------------
Signature: __________________________ _ Date: 
Thank you for your assistance in this project. Please keep a copy of this form for your records. 
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The effects of the menstrual cycle and hormonal contraceptive use 
on the thermo effector threshold temperatures and width of the 
interthreshold zone (EEL 053) 
Environmental Ergonomics Laboratory Fitness Screening Form 
Please read over the questions below*. They are to assist in assessing whether you are fit to participate in 
this study. Please ask the investigators if you have any queries while filling out the fonn. 
Screening Questions* YES NO 
1. Has your doctor ever said that you have a heart condition and that you should only 
do physical activity recommended by a doctor? 
2. Do you feel pain in your chest when you do physical activity? 
3. In the past month, have you had chest pain when you were not doing physical 
activity? 
4. Do you lose your balance because of dizziness or do you ever lose consciousness? 
5. Do you have a bone or joint problem (for example, back, knee or hip) that could be 
made worse by a change in your physical activity? 
6. Is your doctor currently prescribing drugs (for example, water pills) for your blood 
pressure or heart condition? 
7. Do you know of an):: other reason why you should not do physical activity? 
8. Do you have diabetes? 
9. Do you have any bowel or prostate problems (e.g. colitis, irritable bowel syndrome, 
prostate problems) 
10. Neuromuscular (e.g., epilepsy, Multiple Sclerosis, Cerebral Palsy) or skeletal (e.g., 
inflammatory or degenerative arthritis) disorders? 
Name: __________________________________ _ 
Date * * Signature ________________________________ __ 
---------------------
* The wordingfor questions 1-7 are directly copiedfrom the Physical Activity Readiness Questionnaire (PAR-Q) 
developed by the Canadian Society for Exercise Physiology (www.csep.ca). Please let the investigator(s) know if you 
would like to see a copy or for more information. 
* * This screening form becomes invalid if your condition changes so that you cannot answer "no" to any of the 
questions. Please immediately inform the investigators if this is the case or contact Dr. Stephen Cheung (905-688-
5550x5662) if you require further information. 
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EEL 053 Menstrual Cycle History Questionnaire 
(1) When was your last menstrual period? Date: ________________ _ 
(2) On average, how long does your menstrual period last (in days)? __________ _ 
(3) How would you rate your overall discomfort during your menstrual period? (Indicate with a check 
mark on the line scales below) 
Uterine cramping: Very uncomfortable ----------------------------------------------------------Comfortable 
Back pain: Very uncomfortable ----------------------------------------------------------Comfortable 
Mood swings: Very uncomfortable ----------------------------------------------------------Comfortable 
Change in appetite: Very uncomfortable ----------------------------------------------------------Comfortable 
Ability to maintain a comfortable temperature without adding or removing clothing: 
Very uncomfortable ----------------------------------------------------------Comfortable 
(4) On average, how heavy would you rate your blood flow?: Light --------------------------------Heavy 
(5) Have you ever had a menstrual cycle lasting longer than 42 days (the time between two periods)? 
YESD NOD 
Ifyes,when? ______________________________ _ 
(6) Have you ever had a menstrual period with heavy blood loss, lasting longer than 7 days? 
YESD NOD 
Ifyes,when? ______________________________ _ 
(7) Have you ever had an absence of period for 6 months or longer? 
YESD NOD 
Ifyes,when? ______________________________ _ 
(8) Have you ever been pregnant, or are you currently? 
YESD NOD 
Ifyes,when? ______________________________ _ 
*NOTE: The following graphs were created prior to classifying the follicular phase (FP) as Trial 1, and the luteal 
phase (LP) as Trial 2 in the present experiment. Therefore, all data that displays FP data corresponds to Triall, and 
LP data to Trial 2. 
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Fig 9. and Fig 10. (above) Comparison of rectal temperature interthreshold zones between follicular and luteal phases. 
Fig 11. and Fig 12. (below) Comparison of tympanic temperature interthreshold zones between follicular and luteal 
phases. 
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Fig 13. and Fig 14. Changes in rectal and tympanic temperatures . 
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Fig 15. and Fig 16. (above) Comparison of rectal temperature interthreshold zones between follicular and luteal 
phases. 
Fig 17. and Fig 18. (below) Comparison of tympanic temperature interthreshold zones between follicular and luteal 
phases. 
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Fig 19. and Fig 20. Changes in rectal and tympanic temperatures . 
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Fig 21. and Fig 22. (above) Comparison of rectal temperature interthreshold zones between follicular and luteal 
phases. 
Fig 23. and Fig 24. (below) Comparison of tympanic temperature interthreshold zones between follicular and luteal 
phases. 
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Fig 25. and Fig 26. Changes in rectal and tympanic temperatures . 
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Fig 27. and Fig 28. (above) Comparison of rectal temperature interthreshold zones between follicular and luteal 
phases. 
Fig 29. and Fig 30. (below) Comparison of tympanic temperature interthreshold zones between follicular and luteal 
phases. 
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Fig 31. and Fig 32. Changes in rectal and tympanic temperatures . 
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Fig 33. and Fig 34. (above) Comparison of rectal temperature interthreshold zones between follicular and luteal 
phases. 
Fig 35. and Fig 36. (below) Comparison of tympanic temperature interthreshold zones between follicular and luteal 
phases. 
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Fig 37. and Fig 38. Changes in rectal and tympanic temperatures . 
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Fig 39. and Fig 40. (above) Comparison of rectal temperature interthreshold zones between follicular and luteal 
phases. 
Fig 41. and Fig 42. (below) Comparison of tympanic temperature interthreshold zones between follicular and luteal 
phases. 
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Fig 43. and Fig 44. Changes in rectal and tympanic temperatures . 
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Fig 45. and Fig 46. (above) Comparison of rectal temperature interthreshold zones between follicular and luteal 
phases. 
Fig 47. and Fig 48. (below) Comparison of tympanic temperature interthreshold zones between follicular and luteal 
phases. 
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Fig 49. and Fig 50. Changes in rectal and tympanic temperatures . 
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Fig 51. and Fig 52. (above) Comparison of rectal temperature interthreshold zones between follicular and luteal 
phases. 
Fig 53. and Fig 54. (below) Comparison of tympanic temperature interthreshold zones between follicular and luteal 
phases. 
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Fig 55. and Fig 56. Changes in rectal and tympanic temperatures . 
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Fig 57. and Fig 58. (above) Comparison of rectal temperature interthreshold zones between follicular and luteal 
phases. 
Fig 59. and Fig 60. (below) Comparison of tympanic temperature interthreshold zones between follicular and luteal 
phases. 
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Fig 61. and Fig 62. Changes in rectal and tympanic temperatures . 
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Fig 63. and Fig 64. (above) Comparison of rectal temperature interthreshold zones between follicular and luteal 
phases. 
Fig 65. and Fig 66. (below) Comparison of tympanic temperature interthreshold zones between follicular and luteal 
phases. 
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